Microbial melatonin metabolism in the human intestine as a therapeutic target for dysbiosis and rhythm disorders Authors: Petra Zimmermann, Salome Kurth, Benoit Pugin, Nicholas A. Bokulich Published: 2024 ABSTRACT Melatonin (MT) (N-acetyl-5-methoxytryptamine) is an indoleamine recognized primarily for its crucial role in regulating sleep through circadian rhythm modulation in humans and animals. Beyond its association with the pineal gland, it is synthesized in various tissues, functioning as a hormone, tissue factor, autocoid, paracoid, and antioxidant, impacting multiple organ systems, including the gut-brain axis. However, the mechanisms of extra-pineal MT production and its role in microbiota-host interactions remain less understood. This review provides a comprehensive overview of MT, including its production, actions sites, metabolic pathways, and implications for human health. The gastrointestinal tract is highlighted as an additional source of MT, with an examination of its effects on the intestinal microbiota. This review explores whether the microbiota contributes to MT in the intestine, its relationship to food intake, and the implications for human health. Due to its impacts on the intestinal microbiota, MT may be a valuable therapeutic agent for various dysbiosis-associated conditions. Moreover, due to its influence on intestinal MT levels, the microbiota may be a possible therapeutic target for treating health disorders related to circadian rhythm dysregulation. Introduction Melatonin (MT) (N-acetyl-5-methoxytryptamine) is an indoleamine that functions as a hormone, tissue factor, autocoid, paracoid, and antioxidant1. In mammals, including humans, MT is predominantly synthesized in the pineal gland and regulates circadian rhythms2. However, MT can also be synthesized by enterochromaffin cells and bacteria in the intestine. Factors that stimulate MT production in the intestine include the intestinal microbiota and their metabolites (such as short-chain fatty acids), food intake, immune responses, and mitochondrial function3. As MT has been shown to have positive effects on various diseases, including inflammatory bowel disease, obesity, and neuropsychiatric disorders, there may be a significant link between intestinal microbiota and MT. These insights highlight the complex interplay between diet, microbiota, and physiological processes in regulating intestinal MT levels, which could have important implications for treating gastrointestinal and systemic diseases. This review summarizes how MT affects the intestinal microbiota, explores the microbiota’s contribution to intestinal MT levels, and discusses the relevance of intestinal MT production for human health. Evolution MT is one of the earliest compounds to have emerged in living organisms for coordinating essential functions and is phylogenetically one of the most conserved molecules in biology4. In unicellular organisms, MT primarily serves as an antioxidant5,6. Its biosynthetic machinery in eukaryotes likely originated through endosymbiosis of bacteria7, possibly Rhodospirillum rubrum, which is considered a potential precursor of mitochondria7. R. rubrum is one of the oldest known bacteria and also the first bacteria discovered to produce MT8. As multicellular organisms evolved, MT became a signaling molecule that translates environmental light/dark cycles into endocrine signals9. Its receptor-mediated functions were acquired during evolution10. MT is found not only in humans but also in many other animals11 and plants12,13. History MT was first isolated from the bovine pineal gland less than 70 years ago, in 1958, by dermatologist Aaron Lerner14, who named it for its ability to lighten frog skin by affecting melanophores and its chemical relation to serotonin15,16. Lerner later was also the first to isolate MT from humans17. The discovery that MT levels vary between day and night was made in rats in 196418. It took another decade until it was discovered in mice that exposure to light decreases MT production19. MT production and physiological pathways in humans In mammals MT is predominantly synthesized in the pineal gland during dark periods2. Light information is transmitted from the retina to the suprachiasmatic nucleus (SCN) via the retinohypothalamic tract. Specialized photoreceptors in the retina, such as melanopsin-containing ganglion cells, detect light and relay signals to the SCN20,21. The SCN then sends regulates MT production by sending signals to the pineal gland, which does not perceive light directly. Additionally, the SCN receives hormonal signals from the raphe nuclei (serotonin, which sets the circadian phase and body vigilance) and the pineal gland (MT, which facilitates sleep)22. Accordingly, the nocturnal MT production varies seasonally, with longer peaks during winter nights and shorter peaks during summer23. MT’s primary role in humans is regulating circadian rhythms, body temperature, the sleep-wake cycle, cortisol secretion, and blood pressure24. However, it also affects various other organ systems, including the cardiovascular and reproductive systems25–28, body mass index29, and bone growth30,31. Beyond its role as a circadian pacemaker, MT serves as a potent antioxidant and immunomodulator by influencing key regulators such as nuclear factor-kappa B (NF-kB), signal transducer and activator of transcription, NOD-like receptor family pyrin domain containing 3 inflammasome, mitogen-activated protein kinase, and toll-like receptors32–36. It restores glutathione homeostasis and exhibits antiapoptotic and oncostatic effects37–39. MT also influences electrolyte transport across membranes40 and has chelating properties, reducing the cytoplasmic availability of metals41. Substantial amounts of MT are found in tissues and organs frequently exposed to environmental stress, such as the intestine and skin, or those with high oxygen consumption, like the brain42. Additionally, MT production may be upregulated by low-intensity stressors such as dietary restriction or exercise43,44. In the human epithalamus, pinealocytes take up tryptophan from the blood and convert it to serotonin through hydroxylation and decarboxylation. Serotonin is then acetylated into N-acetyl-serotonin by the rate-limiting enzyme arylalkylamine N-acetyltransferase (AA-NAT) (formerly referred to as serotonin N-acetyl transferase), whose activity is upregulated during darkness. Finally, N-acetyl-serotonin is methylated into MT by the enzyme N-acetylserotonin O-methyltransferase (ASMT)45. MT is an amphiphilic molecule, possessing both lipophilic and hydrophilic properties46. In blood, ~70% of MT is bound to albumin47. MT is primarily metabolized in the liver by P450 monooxygenases (CYP1A2) and then conjugated with sulfate or glucuronic acid to become more water-soluble, facilitating excretion into urine, mostly as 6-sulfatoxyMT48 or N1-acetyl-N2-formyl-5-methoxykynuramine42. Although MT can be produced in the cytoplasm, it is primarily synthesized within mitochondria7,49. It performs several critical functions at the mitochondrial level, such as scavenging reactive oxygen species50, helping maintain mitochondrial membrane potential, supports adenosine triphosphate synthesis, and enhances the efficiency of the electron transport chain, regulates mitochondrial dynamics by promoting fusion and reducing fission, which is crucial for maintaining mitochondrial function and cell survival50–52. It also promotes mitophagy, aiding in the removal of damaged mitochondria and maintaining mitochondrial homeostasis50. On the systemic level, MT exerts its effects primarily through interaction with G protein-coupled receptors (GPCRs): MT1 and MT2 receptors. MT1 receptors are widely distributed in the central nervous system, particularly in the SCN of the hypothalamus, the central circadian pacemaker53. MT1 receptors are also found in the retina54, pituitary gland55, and other peripheral tissues, including the cardiovascular system28. MT1 receptors regulate circadian rhythms, which affects sleep and reproductive physiology 53. MT2 receptors, also present in the SCN, are more widely distributed in peripheral tissues than MT1 receptors53. They are present in the retina, various brain areas, and peripheral tissues such as the kidneys, liver, and cardiovascular system28. MT2 receptors modulate phase shifting of circadian rhythms (e.g., adjusting the biological timing during travel across time zones), retinal functions, glucose metabolism, and immune responses56. Additionally, there is a MT3, which is not a traditional GPCR but a cytosolic enzyme called quinone reductase 257. It is found in various tissues, including the liver, kidney, brain and intestine56,58. Its role in MT signaling is less clear but may involve detoxification and protection against oxidative stress. MT production by the intestine and its relation to food intake and circadian rhythm In animals, MT synthesis occurs in various body parts beyond the pineal gland, including the retina59, Harderian gland60, skin61, bone marrow62, macrophages63 and the intestine64–66. In contrast, evidence for extrapineal MT production in humans is limited54,62,67. Some animals studies suggest that after pinealectomy, circadian rhythm of MT levels in blood perist68–72, while others report its abscence73. Due to missing habituation to the light-dark cycle and its effects on MT dynamics some but not all visually impaired humans encounter circadian desynchrony and sleep disturbances74. The concept of intestinal MT production emerged with the identification of MT-producing enzymes in the intestine75,76. Debate continues regarding whether enterochromaffin cells in the intestine produce MT67,77. In animals, MT has been detected from the esophagus to the rectum with the highest levels in the small intestine78,79. Levels of MT in the intestine have been reported to be 400 times higher than in the pineal gland67,80 and 10–100 times higher than in the blood70,78–80, although this has recently been questioned due to the uncertainties in methodological issues with measuring MT67. Similar findings of over 10 times higher MT levels in the intestine compared to circulation have been reported in humans81. Furthermore, MT levels are higher in portal blood than in peripheral venous blood supporting the idea of MT production in the gastrointestinal tract82. While intestinally produced MT can increase serum levels of MT3, it remains unclear how much enters into the cerebrospinal fluid. Therefore, while intestinal MT can have systemic effects, it does not replicate the function of pineal melatonin in regulating the circadian rhythm. In animals, fluctuations in intestinal MT production have been linked to food intake83–85. Specifically, tryptophan administration can increase intestinal production and levels of MT80,86,87. Interestingly, oral administration of L-tryptophan leads to a rapid increase in circulating MT, which is abolished by partial ligature of the portal vein, indicating MT synthesis in the intestine80,88. In humans, diets rich in tryptophan (e.g., white meat, dairy) and MT (e.g., eggs, fish, nuts, some mushrooms, cereals, germinated legumes, wine) also increase MT levels89–92. It has been suggested that the increased MT levels found after tryptophan administration may be due to extrapineal production, though evidence remains controversial93. Interestingly, food deprivation has been shown to increase levels of tryptophan, serotonin, and MT in the intestine of mice94. In humans, however, fasting has been observed to decrease nocturnal circulating MT levels44. These studies highlights that temporal dynamics of MT levels (both intestinal and peripheral) in relation to food intake and fasting still need further elucidation. Recent evidence shows that the intestinal microbiota and its metabolites exhibit diurnal rhythmicity, primarily responding to feeding/fasting cycles95–98. There is a bidirectional relationship where the host’s circadian rhythms influence the gut microbiome, and the microbiome, in turn, affects the host’s circadian clock97,99,100. Microbially derived mediators, such as short-chain fatty acids and bile acids, have been identified as potential signals between the gut microbiome and host circadian clocks101, but it is likely that MT contributes to this. MT production and regulation by bacteria and fungi Intestinal microbiota play crucial roles in regulating serotonin biosynthesis and tryptophan metabolism in the intestine102–104. The availability of intestinal tryptophan can be altered by changes in microbiota composition, as seen in germ-free mice105. Microbiota-derived metabolites, such as bile acids and short-chain fatty acids, stimulate enterochromaffin cells to release serotonin, potentially enhancing MT production106,107. In mice, dysbiosis (disruption in the normal composition of the microbial communities) and germ-free conditions have been shown to directly influence local and systemic MT levels98,108,109. Enterohepatic recirculation of MT is one mechanism by which intestinal microbiota may regulate circulating levels of MT. As previously mentioned, circulating MT is metabolized in the liver via decarboxylation and conjugation (with glucuronic acid or more typically sulfate in humans), allowing excretion in urine or into the intestine via biliary excretion110–113. These compounds could then be deconjugated by microbial enzymes in the intestine, leading to reabsorption and return to circulation114, as observed with other glucuronate- and sulfate-conjugated compounds that undergo enterohepatic recirculation114,115. A few bacteria and fungi also have been shown to synthesize MT (Table 1). The first discovery of bacterial MT production was made in 1995 with R. rubrum, an organism estimated to be 2 to 3.5 billion years old. It was shown that this bacterium produces significantly more MT during extended periods of darkness compared with light periods8. Similarly, Porphyrobacter (formerly Erythrobacter) longus has been shown to produce more MT during darkness116. It has been hypothesized that in bacteria, this variation is passive rather than due to reduced synthesis, possibly linked to depletion from utilization. During daylight hours, photosynthetic organisms may metabolize more MT due to its interaction with reactive oxygen species that are generated in high quantities during photosynthesis. Another example of a MT-producing cyanobacterium is Arthrospira platensis (better known as “Spirulina”)117. Two bacteria colonizing grape plants (Bacillus amyloliquefaciens and Pseudomonas fluorescens) have also been found to produce MT. MT was associated with enhanced plant growth, reduction in reactive oxygen species and mitigation of cell damage118. MT production was upregulated when the plants were exposed to salt or drought stress (Table 1).Table 1Bacteria and fungi that have been identified to produce MTBacteriaImportant findingsBacillus amyloliquefaciensColonization of grapevine plantlets by B. amyloliquefaciens:• increases plant growth214• mitigates adverse effects of salt and drought stress by reducing production214 of malondialdehyde and reactive oxygen species in plant roots214• when grapevine plantlets are exposed to salt or drought stress there is an upregulation of MT synthesis and its intermediates214Rhodospirillum rubrum• higher production in bacteria grown in the dark8Pseudomonas fluorescensColonization of red globe grape roots by P. fluorescens:• increased plant growth118• increased levels of 5-hydroxytryptophan, N-acetylserotonin, and MT118 while decreasing levels of tryptamine and serotonin under salt stress, correlating with reduced reactive oxygen species and mitigated cell damage118Porphyrobacter (formerly Erythrobacter) longus• higher production in bacteria grown in the dark116Arthrospira (formerly Spirulina) platensis• serotonin N-acetyltransferase and hydroxyindole-O-methyltransferase found in S. platensis117FungiImportant findingsMetschnikowia pulcherrima• produced during fermentation119Saccharomyces cerevisiae• produced during fermentation119• decreased MT production in a salt medium120• adding 5-methoxytryptamine to cultures increases MT production120• higher MT production in medium with low levels of reducing sugars121• MT synthesis depended on the yeast growth phase, tryptophan level, reducing sugar levels and growth medium121Saccharomyces uvarum• MT synthesis depended on the yeast growth phase, tryptophan level, reducing sugar levels and growth medium119Tolypocladium guangdongense• increased MT production in response to stress imposed through Congo red, cold, and heat215• decreased levels of MT intermediates in response to Congo red215• key MT synthesis gens upregulated early under stress through Congo red but downregulated later215Torulaspora delbrueckii• produced during fermentation119 Table 1Bacteria and fungi that have been identified to produce MTBacteriaImportant findingsBacillus amyloliquefaciensColonization of grapevine plantlets by B. amyloliquefaciens:• increases plant growth214• mitigates adverse effects of salt and drought stress by reducing production214 of malondialdehyde and reactive oxygen species in plant roots214• when grapevine plantlets are exposed to salt or drought stress there is an upregulation of MT synthesis and its intermediates214Rhodospirillum rubrum• higher production in bacteria grown in the dark8Pseudomonas fluorescensColonization of red globe grape roots by P. fluorescens:• increased plant growth118• increased levels of 5-hydroxytryptophan, N-acetylserotonin, and MT118 while decreasing levels of tryptamine and serotonin under salt stress, correlating with reduced reactive oxygen species and mitigated cell damage118Porphyrobacter (formerly Erythrobacter) longus• higher production in bacteria grown in the dark116Arthrospira (formerly Spirulina) platensis• serotonin N-acetyltransferase and hydroxyindole-O-methyltransferase found in S. platensis117FungiImportant findingsMetschnikowia pulcherrima• produced during fermentation119Saccharomyces cerevisiae• produced during fermentation119• decreased MT production in a salt medium120• adding 5-methoxytryptamine to cultures increases MT production120• higher MT production in medium with low levels of reducing sugars121• MT synthesis depended on the yeast growth phase, tryptophan level, reducing sugar levels and growth medium121Saccharomyces uvarum• MT synthesis depended on the yeast growth phase, tryptophan level, reducing sugar levels and growth medium119Tolypocladium guangdongense• increased MT production in response to stress imposed through Congo red, cold, and heat215• decreased levels of MT intermediates in response to Congo red215• key MT synthesis gens upregulated early under stress through Congo red but downregulated later215Torulaspora delbrueckii• produced during fermentation119 Bacteria and fungi that have been identified to produce MT Colonization of grapevine plantlets by B. amyloliquefaciens: • increases plant growth214 • mitigates adverse effects of salt and drought stress by reducing production214 of malondialdehyde and reactive oxygen species in plant roots214 • when grapevine plantlets are exposed to salt or drought stress there is an upregulation of MT synthesis and its intermediates214 Colonization of red globe grape roots by P. fluorescens: • increased plant growth118 • increased levels of 5-hydroxytryptophan, N-acetylserotonin, and MT118 while decreasing levels of tryptamine and serotonin under salt stress, correlating with reduced reactive oxygen species and mitigated cell damage118 • produced during fermentation119 • decreased MT production in a salt medium120 • adding 5-methoxytryptamine to cultures increases MT production120 • higher MT production in medium with low levels of reducing sugars121 • MT synthesis depended on the yeast growth phase, tryptophan level, reducing sugar levels and growth medium121 • increased MT production in response to stress imposed through Congo red, cold, and heat215 • decreased levels of MT intermediates in response to Congo red215 • key MT synthesis gens upregulated early under stress through Congo red but downregulated later215 Several fungi have been found to produce MT during fermentation processes (Metschnikowia pulcherrima, Saccharomyces cerevisiae, Saccharomyces uvarum, and Torulaspora delbrueckii) (Table 1)119–121. The synthesis of MT in these fungi was influenced by growth phase, tryptophan levels, reducing sugar levels, and the composition of the growth medium120,121. S. cerevisiae, commonly known as baker’s yeast, is occasionally found in the human intestinal microbiota122–124. M. pulcherrima and T. delbrueckii are less likely to be found in the human intestinal microbiota, as they are typically associated with other environments such as fruits, soil, or fermenting plants125. Little is known about the enzymes involved in MT biosynthesis in microorganisms. However, some have been identified in bacteria, such as AA-NATin the cyanobacterium Synechocystis sp. PCC 6803126 and several Staphylococcus spp127. These enzymes can also acetylate tryptamine, a tryptophan catabolite and serotonin precursor produced by intestinal microbes104. In S. cerevisiae, an AA-NAT has been identified128. Interestingly, the biochemical characterization of certain AA-NAT enzymes revealed higher substrate affinity with 5-methoxytryptamine (5-MT) than serotonin126,128, suggesting that an alternative pathway, where serotonin is first O-methylated to 5-MT and then N-acetylated to MT, may be predominant in microorganisms129. Influence of MT on bacteria and fungi It has been shown that MT enhanced the swarming activity of the intestinal bacteria Klebsiella aerogenes (formerly Enterobacter), exhibiting a rhythmic pattern with a circadian period of ~24 h130. Recently, a study found that MT increases the size of K. aerogenes colonies and synchronizes its circadian clock in a dose-dependent manner131. Exposure to MT induced the expression of 81 transcripts during exponential growth and 30 transcripts during early stationary phase. These transcripts predominantly included genes involved in biofilm formation, fimbria biogenesis, transcriptional regulation, carbohydrate transport and metabolism, phosphotransferase systems, stress response, and metal ion binding and transport. Notably, the differential expression of biofilm and fimbria-related genes suggests that MT might enhance K. aerogenes’ capacity for host colonization (Table 2).Table 2Summary of findings of studies investigating the effect of MT on bacteria and fungiBacteriaImportant findingsAcinetobacter baumannii• inhibited growth132Klebsiella (formerly Enterobacter) aerogenes• MT causes an increase in the swarming activity of K. aerogenes which occurs rhythmically with a period of ~24 h130• possible coordination between circadian clocks of host (mammals) and microbiota (such as K. aerogenes) in intestine130• MT increases the size of macrocolonies (clusters of bacterial cells) on semisolid agar and synchronizes the circadian clock of K. aerogenes in a level-dependent manner131• 81 transcripts showed differential expression during exponential growth and 30 transcripts showed differential expression during early stationary phase in response to MT131• MT-sensitive genes are involved in various biological processes such as biofilm formation, fimbria biogenesis, transcriptional regulation, carbohydrate transport and metabolism, phosphotransferase systems, stress response, and metal ion binding and transport131• MT might enhance the ability of K. aerogenes to colonize its host potentially influencing its ecological role in the intestine131Mycobacterium tuberculosis• inhibited growth133Mycobacterium bovis• inhibited growth133Pseudomonas aeruginosa• inhibited growth132Staphylococcus aureus• inhibited growth132Xanthomonas oryzae• inhibited growth, motility, and biofilm formation134,135• reduced mRNA expression of genes involved in cell division, toxin production, carbohydrate and amino acid metabolism134,135FungiImportant findingsSaccharomyces cerevisiae• MT supplementation attenuates the negative effects of ethanol on S. cerevisiae (reduced growth, increased mortality rates, higher levels of reactive oxygen species, lipid peroxidation)138• protective effects of MT varies depending on strain, level of MT, and growth phase138 Table 2Summary of findings of studies investigating the effect of MT on bacteria and fungiBacteriaImportant findingsAcinetobacter baumannii• inhibited growth132Klebsiella (formerly Enterobacter) aerogenes• MT causes an increase in the swarming activity of K. aerogenes which occurs rhythmically with a period of ~24 h130• possible coordination between circadian clocks of host (mammals) and microbiota (such as K. aerogenes) in intestine130• MT increases the size of macrocolonies (clusters of bacterial cells) on semisolid agar and synchronizes the circadian clock of K. aerogenes in a level-dependent manner131• 81 transcripts showed differential expression during exponential growth and 30 transcripts showed differential expression during early stationary phase in response to MT131• MT-sensitive genes are involved in various biological processes such as biofilm formation, fimbria biogenesis, transcriptional regulation, carbohydrate transport and metabolism, phosphotransferase systems, stress response, and metal ion binding and transport131• MT might enhance the ability of K. aerogenes to colonize its host potentially influencing its ecological role in the intestine131Mycobacterium tuberculosis• inhibited growth133Mycobacterium bovis• inhibited growth133Pseudomonas aeruginosa• inhibited growth132Staphylococcus aureus• inhibited growth132Xanthomonas oryzae• inhibited growth, motility, and biofilm formation134,135• reduced mRNA expression of genes involved in cell division, toxin production, carbohydrate and amino acid metabolism134,135FungiImportant findingsSaccharomyces cerevisiae• MT supplementation attenuates the negative effects of ethanol on S. cerevisiae (reduced growth, increased mortality rates, higher levels of reactive oxygen species, lipid peroxidation)138• protective effects of MT varies depending on strain, level of MT, and growth phase138 Summary of findings of studies investigating the effect of MT on bacteria and fungi • MT causes an increase in the swarming activity of K. aerogenes which occurs rhythmically with a period of ~24 h130 • possible coordination between circadian clocks of host (mammals) and microbiota (such as K. aerogenes) in intestine130 • MT increases the size of macrocolonies (clusters of bacterial cells) on semisolid agar and synchronizes the circadian clock of K. aerogenes in a level-dependent manner131 • 81 transcripts showed differential expression during exponential growth and 30 transcripts showed differential expression during early stationary phase in response to MT131 • MT-sensitive genes are involved in various biological processes such as biofilm formation, fimbria biogenesis, transcriptional regulation, carbohydrate transport and metabolism, phosphotransferase systems, stress response, and metal ion binding and transport131 • MT might enhance the ability of K. aerogenes to colonize its host potentially influencing its ecological role in the intestine131 • inhibited growth, motility, and biofilm formation134,135 • reduced mRNA expression of genes involved in cell division, toxin production, carbohydrate and amino acid metabolism134,135 • MT supplementation attenuates the negative effects of ethanol on S. cerevisiae (reduced growth, increased mortality rates, higher levels of reactive oxygen species, lipid peroxidation)138 • protective effects of MT varies depending on strain, level of MT, and growth phase138 In contrast to the increased colony sizes of K. aerogenes130, MT exposure inhibits growth of Acinetobacter baumannii132, Mycobacterium tuberculosis133, Mycobacterium bovis133 Pseudomonas aeruginosa132 Staphylococcus aureus132, and Xanthomonas oryzae134,135. In X. oryzae, MT has also been shown to lead to reduced mRNA expression of genes associated with cell division, toxin production, as well as carbohydrate and amino acid metabolism134,135. MT can inhibit bacterial growth by regulating gene expression associated with cell division134,135 and metabolism135, reducing cytoplasmic availability of metal ions41, restricting linoleic acid absorption (used for cell proliferation)136, and enhancing bacterial outer membrane permeability (Fig. 1)137.Fig. 1Intestinal melatonin and its effects. Intestinal melatonin and its effects. A further example that MT is produced in response to environmental stress can be taken from fungi. During alcoholic fermentation, Saccharomyces cerevisiae faces various stresses, with ethanol being particularly significant. MT supplementation attenuates the negative effects of ethanol on S. cerevisiae (reduced growth, increased mortality rates, higher levels of reactive oxygen species, and lipid peroxidation)138. The protective effect varies depending on the strain, MT level, and growth phase. Influence of MT on the composition of the intestinal microbiota In total, 14 studies investigated the effect of MT on the composition of the intestinal microbiota in 663 mice (mean 44, range 8–96 per study) (Table 3)108,109,139–149. This included mice exposed to toxins (aflatoxin B n = 6139, ochratoxin A n = 60150) or to stress (sleep deprivation n = 87108,109, water n = 12144, water and sleep deprivation n = 12144, restraint n = 24142, jet-lag n = 12151), with chemically-induced colitis (oxazolone n = 8141, dextran-sodium sulfate n = 100140,143,147), with spinal cord injury (n = 44)145, receiving a high-fat diet (n = 30)146,149, receiving antibiotics (n = 35)148,150, only receiving MT (n = 64)142,143,145,148,151, as well as germ-free (n = 20)148 and control mice (n = 139)108,109,139,140,142–146,148–151. In total, 298 (45%) mice received MT, which was injected intraperitoneally (n = 172)108,109,142–145, given orally (n = 117)139,140,146–151 or injected into the colon (n = 9)141. The doses of MT can be found in Table 1.Table 3Summary of findings of studies investigating the effect of MT on the composition and function of the intestinal microbiotaAuthorStudypopulationCountryPublication yearCharacteristics and housing conditions of animalsNumber of animals and interventionsSample typeDNA extraction kitMicrobiota analysis techniqueSequenced region and primersSequencing platformSequencing length, depthDatabase for taxonomic identificationDatabase for metabolic pathwaysEffect on the microbiota and metabolic pathwaysOther findingsLiu et al.139Mice exposed to aflatoxin B1China20226w-old male C57BL/6 mice, standard dietLight conditions nr2 alfatoxin B1 (0.75 ng/kg/d) orally for 2w2 alfatoxin B1 (0.75 ng/kg/d) and MT (20 mg/kg/d) orally for 2w2 alfatoxin B1 (0.75 ng/kg/d), MT (20 mg/kg/d) and glycine-betaine-muricholic acid (10 mg/kg/d) orally for 2w2 controlsColon contentDNeasy PowerSoil Kit (Qiagen)16S rRNA gene sequencingV3, V4, nrnrnr, nrnrN/AAlfatoxin B1-exposed mice receiving MT (n = 2) compared with alfatoxin B1-exposed mice without MT (n = 2)• Higher richness and diversity (number of OTUs, ACE, Chao, Shannon, and Simpson indices)• Lower relative abundance of Bacillota, and higher relative abundance of Bacteroidetes• Lower relative abundances of Clostridiales and Lactobacillales• Lower relative abundances of Desulfovibrio, Clostridium_XIVa, and LactobacillusAlfatoxin B1-exposed mice receiving MT (n = 2) compared with alfatoxin B1-exposed mice without MT (n = 2)• Higher expression of intestinal tight junction proteins (claudin-1, occluding, zonula occludens-1), and lower intestinal permeability in ileum• Lower levels of lipopolysaccharides in serum and liver (not in antibiotic-treated mice)• Higher levels of farnesoid X receptor protein and lower levels TLR4/NF-κB signalling pathway-related mRNA, as well as lower expression of TLR4, MyD88, p-p65, and p-IκB in ileum (not in mice treated with glycine-betaine-muricholic acid)Jing et al.140Mice with DSS-induced colitisChina20226 to 8w-old male C57BL/6 mice, standard dietLight conditions nr8 3%-DSS in drinking water for 7 d8 3%-DSS in drinking water for 7 d followed by 5-aminosalicylic acid (50 mg/kg/d)8 3%-DSS in drinking water for 7 d followed by hyaluronic acid orally for 7 d8 3%-DSS in drinking water for 7 d followed by MT orally for 7 d8 3%-DSS in drinking water for 7 d followed by hyaluronic acid and MT orally for 7 d8 controlsStoolTianamp stool DNA kit (Tiangen)16S rRNA gene sequencingV3, V4, 338 F/806 RNrnr, nrGreengenes 13_8N/AMice with colitis receiving MT (n = 16) ± hyaluronic acid compared to mice with colitis without MT (n = 8)• Higher richness and diversity (number of OTUs, Shannon index)• Higher relative abundance of Bacillota• Higher relative abundance of Lactobacillus, lower relative abundance of Bacteroides, Blautia, and StreptococcusMice with colitis receiving MT (n = 16) ± hyaluronic acid compared to mice with colitis without MT (n = 8)• Improvement of colitis symptoms, decreased colon weight/length ratio, decreased spleen size, alleviation of damaged intestinal barrier, decreased colon inflammation (more uniform crypt structure and decreased inflammatory cell infiltration)• Higher expression of intestinal tight junction proteins in colon (occluding, zonula occludens-1),Zhao et al.141Mice with oxazolone-induced colitisChina20226 to 8w-old male C57BL/6 mice, nrLight conditions nr9 3% oxazolone (4.5 uL/g) injected into colon9 MT (50 mg/kg/d) orally for 7 d before 3% oxazolone (4.5 uL/g) injected into colonStoolEZNA soil kit (Omega Bio-Tek)16S rRNA gene sequencingV3, V4, 338 F, 806 RMiSeq 2500 (Illumina)nr, nrnrN/AMice with colitis receiving MT (n = 6) compared with mice with colitis without MT (n = 6)• Lower richness and diversity (ACE, Chao, and Shannon indices)• Higher relative abundances of Verrucomicrobiota and Actinomycetota• Lower relative abundance of Lachnospiraceae and Peptococcaceae• Higher relative abundances of Bifidobacterium and lower relative abundances of DesulfovibrioMice with colitis receiving MT (n = 9) compared with mice with colitis without MT (n = 9)• Higher body weight, less colon shortening, and lower histological pathology score in colon• Lower levels of neutrophils, TNF-α, IL-1ß, IL-5, and IL-13 in colon• Higher expression of tight junction proteins (occludin, zonula occludens-1) in colonLin et al.142Mice exposed to restraint stressChina20218w-old male IRC mice, standard diet14 h light/10 h dark cycles12 restraint for 3 d12 restraint and MT (20 mg/kg/d) intraperitoneally for 3 d12 MT (20 mg/kg/d) intraperitoneally for 3 d12 controlsColon contentDNeasy PowerSoil Kit (Qiagen)16S rRNA gene sequencingV3, V4, 338 F, 806 RHiSeq 2500 (Illumina)2×250, mean 79,928 reads/sampleRibosomal Database ProjectKEGGMice exposed to restraint stress receiving MT (n = 5) compared with mice exposed to restraint stress without MT (n = 5)• No difference in richness and diversity (number of OTUs, ACE, Chao1, Shannon, and Simpson indices)• Lower relative abundances of Bacteroides and Tyzzerella, and higher relative abundance of Mucispirillum, Oscillibacter, and Peptococcus• Higher relative abundance of microbiotas involved in tryptophan metabolism, benzoate degradation and synthesis and degradation of ketone body pathways, and lower relative abundance of microbiotas involved in alanine, aspartate and glutamate metabolism, glutamate metabolism, GABAergic synapses and central carbon metabolism in cancer pathwaysMice exposed to restraint stress receiving MT compared (n = 12) with mice exposed to restraint stress without MT (n = 12)• Higher corticosterone levels, lower MT levels, and higher reactive oxygens species plasma• Lower expression of TLR2, TLR4, p-p65, and p-IκB in colonRong et al.151Mice with jetlagChina20218w-old male C57BL/6 mice, standard diet12 h light/12 h dark cycles (or specific cycles to induce jetlag)6 jetlag6 jet lag and MT (0.4 mg/mL) in drinking water6 MT (0.4 mg/mL) in drinking water6 controlsStoolnr16S rRNA gene sequencingV3, V4, nrMiSeq (Illumina)nr, nrnrN/AJet-lagged mice receiving MT (n = 6) compared with jet-lagged mice without MT (n = 6)• Lower diversity (Shannon index), no difference in Simpson index• Lower relative abundance of Enterobacteriales• Higher relative abundance of A. muciniphilaJet-lagged mice receiving MT (n = 6) compared with jet-lagged mice without MT (n = 6)• Lower body weight and lipid intake• Lower lipid accumulation in ileum• Lower epididymal white adipose tissue around epididymis• Lower lipopolysaccharides in serum• Lower expression of TLR4, MyD88, and nuclear factor interleuktin-3-regualted protein in ileum• Restored circadian amplitude of nuclear receptor subfamily 1 group D member 1 and nuclear factor interleuktin-3-regualted protein• Lower TLR4/IL-22/STAT3 signalling pathway activity and higher angiopoietin-like 4 levels in ileumZhang et al.150Mice exposed to ochratoxin AChina20216w-old male C57BL/6 mice, standard diet12 h light/12 h dark cycles15 ochratoxin A (250 ug/kg/d) orally for 3w15 ochratoxin A (250 ug/kg/d) and MT (15 mg/kg/d) orally for 3w15 controls15 antibiotics (vancomycin 0.5 g/L,ampicillin 1 g/L, gentamicin 1 g/L, and streptomycin 1 g/L) orally for 3w15 antibiotics (vancomycin 0.5 g/L,ampicillin 1 g/L, gentamicin 1 g/L, and streptomycin 1 g/L) and ochratoxin A (250 ug/kg/d) orally for 3w15 antibiotics (vancomycin 0.5 g/L,ampicillin 1 g/L, gentamicin 1 g/L, and streptomycin 1 g/L), ochratoxin A and MT (15 mg/kg/d) (250 ug/kg/d) orally for 3wColon contentnr16S rRNA gene sequencingV3, V4, nrMiSeq (Illumina)nr, nrnrN/AOchratoxin A-exposed mice receiving MT (n = 8) compared with ochratoxin A-exposed mice without MT (n = 8) (not in antibiotic treated mice)• Higher richness and diversity (ACE, Chao1, Shannon, and Simpson indices)• Higher relative abundance of Bacteroidetes, and lower relative abundance of Bacillota• Lower relative abundance of Erysipelotrichales, and higher relative abundances of Bacteroidales and Clostridiales• Lower relative abundances of Lactobacillus and Desulfovibrio, and higher relative abundance of BacteroidesOchratoxin A-exposed mice receiving MT (n = 15) compared with ochratoxin A-exposed mice without MT (n = 15) (not in antibiotic-treated mice)• Higher weight gain and feed intake• Lower liver to body weight ratio• Lower levels of alkaline phosphatase, gamma-glutamyl transferase, low-density lipoprotein, and triglycerides, and higher levels of total protein, albumin, creatinine kinase in serum• Higer levels of antioxidant enzyme activities and lower levels of maleic dialdehyde in liver• Lower levels of TNF-α, IL-6, IL-1ß, and lipopolysaccharides in liver and ileum• Lower levels of reactive oxygen species, and apoptotic and necrotic cells in liver• Higher mitochondrial membrane potential and adenosine triphosphate in liver• Higher levels of short-chain fatty acids, lower levels of lipopolysaccharides in colon• Restored ileal morphology and permeability (disrupted by ochratoxin A)• Restored protein-expression related to apoptosis, autophagy, antioxidants, inflammation and tight junctions in liver (disrupted by ochratoxin A)• Restored ileum permeability (disrupted by ochratoxin A)Gao et al.109Mice with sleep deprivationChina2020Adult male ICR-CD1 mice, standard diet14 h light/10 h dark cycles5 sleep-deprived for 3 d5 sleep-deprived and MT (20 mg/kg/d) intraperitoneally for 3 d5 sleep-deprived and MT (40 mg/kg/d) intraperitoneally for 3 d5 controlsJejunal contentQIAamp DNA Stool Mini Kit (Qiagen)16S rRNA gene sequencingV3, V4, composite specific primersMiSeq (Illumina)nr, mean 75,221 reads/samplenrKEGGSleep-deprived mice receiving MT (n = 10) compared with sleep-deprived mice without MT (n = 5)• Higher richness and diversity (number of OTUs, ACE, Chao1, and Shannon indices), lower Simpson index• Higher relative abundance of Bacillota, and lower relative abundance of Bacteroidetes• Higher relative abundances of Bacteroidacea and Prevotellaceae, and lower relative abundances of Moraxellaceae and Aeromonadaceae• Lower abundance of pathways of cell wall/membrane/envelope biogenesis, energy production and conversion, replication, recombination and repair and translation, ribosomal structure and biogenesis, and higher abundance of pathway of carbohydrate transport and metabolism and transcriptionSleep-deprived mice receiving MT (n = 10) compared with sleep-deprived mice without MT (n = 5)• Lower cortisol levels in plasma• Higher levels of IL-22, and lower levels of IL-17 and reactive oxygen species in jejunumKim et al.143Mice with DSS-induced colitisChina20208 to 9w-old male BALB/c and WT/TLR4 KO mice, standard diet14 h light/10 h dark cyclesBALB/c:10 2.5%-DSS in drinking water for 6 d10 2.5%-DSS in drinking water plus MT (10 mg/kg/d) intraperitoneally for 8 d10 MT (10 mg/kg/d) intraperitoneally for 8 d10 controlsTLR KO:10 2.5%-DSS in drinking water for 6 d10 2.5%-DSS in drinking water plus MT (10 mg/kg/d) intraperitoneally for 8 d10 MT (10 mg/kg/d) intraperitoneally for 8 d10 controlsStoolFastDNA Spin Kit for Soil (MP Biomedicals)16S rRNA gene sequencingV3, V4, nrnrnr, nrEzTaxon-eN/AMice with colitis receiving MT (n = 5) compared with mice with colitis without MT (n = 5)• Higher richness (Chao index)• Lower relative abundance of Pseudomonadota, trend towards higher relative abundance of Bacillota, and trend towards lower relative abundance of Bacteroidetes• Higher relative abundance of RuminococcaceaeMice with colitis receiving MT (n = 10) compared with mice with colitis without MT (n = 10) (not in TLR4-knock-out mice)• Less colitis symptoms (lower disease activity index)• Lower histological pathology score in colon• Higher number of goblet cells in colon• Less colon shortening• Higher number of goblet cells in colon• Lower levels of IL-1ß, IL-17α, and higher levels of MT receptors and regenerating islet-derived protein 3-ß in colon• Higher expression of MT receptors in colonPark et al.144Mice with sleep deprivation exposed to water stressKorea20209w-old male C57BL/6 mice, standard diet12 h light/12 h dark cycles6 exposed to water stress for 10 d6 exposed to water stress and MT (10 mg/kg/d) intraperitoneally for 10 d6 exposed to water stress and sleep-deprived for 10 d6 exposed to water stress, sleep-deprived and MT (10 mg/kg/d) intraperitoneally for 10 d6 controlsStool samplesnr16S rRNA gene sequencingV3, V4, 341 F, 805 RMiSeq (Illumina)EzTaxon-eMice exposed to water stress ± sleep-deprivation receiving MT (n = 6) compared with mice exposed to water stress ± sleep-deprivation without MT (n = 12)• No difference in richness or diversity (number of OTUs, Shannon, and Simpson indices)• Lower relative abundances of Erysipelotrichaceae• Higher relative abundances of Lactobacillus• Higher relative A. muciniphila, and lower relative abundances of P. massiliensisMice exposed to water stress ± sleep-deprivation ± MT (n = 24) compared with controls (n = 6)• Lower weight, no difference in colon length or inflammationGao et al.108Mice with sleep deprivationChina20198w-old male CD1 mice, standard diet14 h light/10 h dark cycles24 sleep-deprived for 3 d24 sleep-deprived and MT (20 mg/kg/d) intraperitoneally for 3 d24 sleep-deprived and MT (40 mg/kg/d) intraperitoneally for 3 d24 controlsColon contentQIAamp DNA Stool Mini Kit (Qiagen)16S rRNA gene sequencingV3, V4, nrMiSeq (Illumina)nr, mean 74,133 reads/samplenrSleep-deprived mice receiving MT (n = 10) compared with sleep-deprived mice without MT (n = 5)• Higher richness (number of OTUs, ACE, Chao1, and Shannon indices), lower Simpson index• Lower relative abundance of Bacillota, and higher relative abundance of Bacteroidetes• Higher relative abundance of Akkermansia, Bacteroides, and Faecalibacterium, and lower relative abundance of AeromonasSleep-deprived mice receiving MT (n = 24) compared with sleep-deprived mice without MT (n = 24)• Lower norepinephrine levels in plasma• Higher levels of anti-inflammatory (IL-5, IL-10, and IFN-y) and lower levels of pro-inflammatory cytokines (TNF-α, IL-1ß, and IL-6) in plasma• Higher levels of antioxidant enzymes (glutathione peroxidase, superoxide dismutase, and catalase), lower total antioxidant capacity, and lower malondialdehyde levels (lipid peroxidation) in colon• Higher number of goblet cells, proliferation cell nuclear antigen-positive cells, mucin 2 expression, and tight junction protein expression (claudin-1, occluding, zonula occludens-1) in colonJing et al.145Mice with spinal cord injuryChina2019Adult female C57BL/6 mice, standard diet12 h light/12 h dark cycles16 spinal cord injury16 spinal cord injury and MT (10 mg/kg twice daily) intraperitoneally for 4w16 MT (10 mg/kg twice daily) intraperitoneally for 4w16 controls6 antibiotics (ampicillin 0.2 g/L, neomycin 0.2 g/L, metronidazole 0.2 g/L, vancomycin 0.1 g/L) 2w before and 4w after spinal cord injury6 antibiotics (ampicillin 0.2 g/L, neomycin 0.2 g/L, metronidazole 0.2 g/L, vancomycin 0.1 g/L) 2w before and 4w after spinal cord injury and MT 10 mg/kg twice daily intraperitoneal 4wStool samplesE.Z.N.A. Stool DNA Kit (Omega Bio-Tek)16S rRNA gene sequencingV3, V4, 338 F, 806 RMiSeq (Illumina)2×300, mean 33,999 reads/sampleSILVA (SSU128)N/ACultureColumbia blood agar, 38°C, 48 hMice with spinal cord injury receiving MT (n = 5) compared with mice with spinal cord injury without MT (n = 5)• Lower richness and diversity (ACE and Shannon indices)• Lower relative abundance of Clostridiales, higher relative abundance of Lactobacillales (Lactobacillus)Mice receiving MT (n = 5) compared with controls without spinal injury or MT (n = 5)• No difference in microbiota compositionMice with spinal cord injury receiving MT (n = 16) compared with mice with spinal cord injury without MT (n = 16)• Higer intestinal barrier integrity (tight junctions) and intestinal motility, reduced expression levels of proinflammatory cytokines (IL-17, IFNy, and monocyte chemoattractant protein-1)• Improved weight gain and metabolic profiling• Promoted locomotor recoveryMice with spinal cord injury without MT (n = 16) compared with controls without spinal injury or MT (n = 16)• Lower levels of MT in colonic tissue• Increased intestinal permeabilityYin et al.146Mice on high-fat dietChina2018Adult female ICR mice, standard or high-fat diet12 h light/12 h dark cycles10 high-fat diet for 2w10 high-fat diet and MT (0.4 mg/mL) in drinking water ( = approximately 108 mg/kg/d) for 2w10 controlsStool samplesnr16S rRNA gene sequencingV3, V4,MiSeq (Illumina)nr, mean 72,497 reads/sampleSILVAKEGGMice on high-fat diet receiving MT (n = 8) compared with mice on high-fat diet without MT (n = 8)• Higher diversity (Shannon and Simpson indices), no difference in richness (number of OTUs)• Lower relative abundance of Bacillota, and higher relative abundance of Bacteroidetes• Lower relative abundances of Lactobacillales, and higher relative abundances of Bacteroidales, Erysipelotrichales, and Burkholderiales• Lower relative abundances of Lactobacillus, Bacteroides, Alistipes, and Parasutterella• Higher metabolism of amino acid, energy, and cofactors and vitamins, lower membrane transport and carbohydrate metabolism, and lower relative abundance of lipid metabolism-related genesMice on high-fat diet receiving MT (n = 10) compared with mice on high-fat diet without MT (n = 10)• Lower weight of subcutaneous adipose tissue• Lower lipid accumulation in liver• Lower levels of triglycerides in serum• Higher mRNA expression of peroxisome proliferator-activated receptor alpha and liver X receptor beta, and lower mRNA expression of sterol regulatory element-binding protein 2 in subcutaneous adipose tissue• Higher mRNA expression of peroxisome proliferator-activated receptor alpha, liver X receptor beta, and acetyl-coenzyme A carboxylase in liverZhu et al.147Mice with DSS-induced colitisChina20188w-old ICR mice, standard diet12 h light/12 h dark cycles10 5%-DSS in drinking water for 1w10 5%-DSS and MT (0.2 mg/L) in drinking water for 1wColon contentnr16S rRNA gene sequencingV3, V4, 515 F, 907 RMiSeq (Illumina)2×250, mean 8,198 reads/sampleSILVA (SSU115)N/AMice with colitis receiving MT (n = 10) compared with mice with colitis without MT (n = 10)• No difference in richness or diversity (ACE, Chao1, Shannon, and Simpson indices)• Higher relative abundance of Bacillota, and lower relative abundance of Bacteroidetes• Higher relative abundances of Coprococcus_1 and Ruminococcaceae_UCG-014Mice with colitis receiving MT (n = 10) compared with mice with colitis without MT (n = 10)• Higher antioxidant capability in plasma (measured by 2,2’-azino-bis3-ethylbenz-thiazoline-6-sulfonic acid radical cation decolorization assay)Ren et al.148Weanling miceChina20173w-old male ICR mice, standard diet12 h light/12 h dark cycles10 MT (0.2 g/L) in drinking water for 2w10 controls10 antibiotics (streptomycin 1 g/L, ampicillin 1 g/L, gentamicin 1 g/L, and vancomycin 0.5 g/L) orally for 2w10 antibiotics (streptomycin 1 g/L, ampicillin 1 g/L, gentamicin 1 g/L, and vancomycin 0.5 g/L) and MT (0.2 g/L) orally for 2w10 germ-free mice10 germ-free mice receiving MT (0.2 g/L) orally for 2wStool samplesQIAamp DNA Stool Mini Kit (Qiagen)16S rRNA gene sequencingV3, V4, 338 F, 806 RMiSeq (Illumina)2×250, nrSILVAKEGGMice receiving MT (n = 8) compared with controls without MT (n = 8)• Higher richness (number of OTUs, ACE, and Chao1 indices)• Lower relative abundances of Bacteroidetes• Lower relative abundance of Bacteroidales• Lower relative abundance Prevotellaceae• Higher relative abundance of Lactobacillus (L. intestinalis, L. johnsonii, and L. reuteri)• Altered microbial metabolism, including amino acid metabolism, polycyclic aromatic hydrocarbon degradation, degradation of aromatic compounds and drug metabolism (4-aminobenzoic acid, 2-indanone, p-cresol, malonamide, saccharic acid, 4-hydroxybenzoic acid, threitol, 7,8-dimethylalloxazine, 6-hydroxy caproic acid dimer, 6-methylmercaptopurine, 5′-methylthioadenosine, palatinitol, cis-2- hydroxycinnamic acid, 2-carboxybenzaldehyde, and saccharopine)Mice receiving MT (n = 10) compared with controls without MT (n = 10)• Higher weight gain (not in antibiotic-treated or germ-free mice)• Improved intestinal morphology (villus length, crypt depth, villus to crypt ratio) (not in antibiotic-treated or germ-free mice)• Lower bacterial load in mice infected with enterotoxigenic E. coli (not in antibiotic-treated mice)Xu et al.149Mice on high-fat dietChina201710w-old male C57BL/6 J mice, standard diet or high-fat diet12 h light/12 h dark cycles5 high-fat diet for 10w5 high-fat diet plus MT (50 mg/kg/d) orally for 10w5 controlsStool samplesQIAamp DNA Stool Mini Kit (Qiagen)16S rRNA gene sequencingV3, V4, composite specific bacterial primersMiSeq (Illumina)nr, mean 60,983 reads/samplenrN/AMice on high-fat diet receiving MT (n = 5) compared with mice on high-fat diet without MT (n = 5) or mice on standard diet without MT (n = 5)• Lower richness and diversity (lower number of OTUs, lower ACE, Chao1, and Shannon indices), higher Simpson index• Lower relative abundance of Bacillota, higher relative abundance of Bacteroidetes and higher relative abundance of Verrucomicrobiota• Lower relative abundance of Desulfovibrionaceae (only compared with mice without MT on high-fat diet)• Higher relative abundance of Akkermansia and lower relative abundaunce of Alstipes, Anaerotruncus, and Helicobacter_marmotae (only compared with mice without MT on high-fat diet)Mice on high-fat diet receiving MT (n = 5) compared with mice on high-fat diet without MT (n = 5) Decreased weight gain, liver steatosis, insulin resistance and low-grade inflammationACE – abundance-based coverage estimatorNF-κB – nuclear factor-kappa BC57BL/6 – C57 Black 6nr – not reportedd – daysMyD88 - myeloid differentiation primary response gene 88DSS - DSSOTU – operational taxonomic unith – hourp-p65 – phosphorylated p65ICR – institute of cancer researchp-IκB – phosphorylated inhibitor of kappa BIFN – interferonSTAT3 - signal transducer and activator of transcription 3IL – interleukinTLR – toll-like receptorKEGG – Kyoto encyclopedia of genes and genomesTNF-α – tumor necrosis factor alphamRNA – messenger ribonucleic nucleic acidw – weekN/A – not applicableWT/TLR4 KO mice – wild-Type/Toll-Like Receptor 4 Knockout mice Table 3Summary of findings of studies investigating the effect of MT on the composition and function of the intestinal microbiotaAuthorStudypopulationCountryPublication yearCharacteristics and housing conditions of animalsNumber of animals and interventionsSample typeDNA extraction kitMicrobiota analysis techniqueSequenced region and primersSequencing platformSequencing length, depthDatabase for taxonomic identificationDatabase for metabolic pathwaysEffect on the microbiota and metabolic pathwaysOther findingsLiu et al.139Mice exposed to aflatoxin B1China20226w-old male C57BL/6 mice, standard dietLight conditions nr2 alfatoxin B1 (0.75 ng/kg/d) orally for 2w2 alfatoxin B1 (0.75 ng/kg/d) and MT (20 mg/kg/d) orally for 2w2 alfatoxin B1 (0.75 ng/kg/d), MT (20 mg/kg/d) and glycine-betaine-muricholic acid (10 mg/kg/d) orally for 2w2 controlsColon contentDNeasy PowerSoil Kit (Qiagen)16S rRNA gene sequencingV3, V4, nrnrnr, nrnrN/AAlfatoxin B1-exposed mice receiving MT (n = 2) compared with alfatoxin B1-exposed mice without MT (n = 2)• Higher richness and diversity (number of OTUs, ACE, Chao, Shannon, and Simpson indices)• Lower relative abundance of Bacillota, and higher relative abundance of Bacteroidetes• Lower relative abundances of Clostridiales and Lactobacillales• Lower relative abundances of Desulfovibrio, Clostridium_XIVa, and LactobacillusAlfatoxin B1-exposed mice receiving MT (n = 2) compared with alfatoxin B1-exposed mice without MT (n = 2)• Higher expression of intestinal tight junction proteins (claudin-1, occluding, zonula occludens-1), and lower intestinal permeability in ileum• Lower levels of lipopolysaccharides in serum and liver (not in antibiotic-treated mice)• Higher levels of farnesoid X receptor protein and lower levels TLR4/NF-κB signalling pathway-related mRNA, as well as lower expression of TLR4, MyD88, p-p65, and p-IκB in ileum (not in mice treated with glycine-betaine-muricholic acid)Jing et al.140Mice with DSS-induced colitisChina20226 to 8w-old male C57BL/6 mice, standard dietLight conditions nr8 3%-DSS in drinking water for 7 d8 3%-DSS in drinking water for 7 d followed by 5-aminosalicylic acid (50 mg/kg/d)8 3%-DSS in drinking water for 7 d followed by hyaluronic acid orally for 7 d8 3%-DSS in drinking water for 7 d followed by MT orally for 7 d8 3%-DSS in drinking water for 7 d followed by hyaluronic acid and MT orally for 7 d8 controlsStoolTianamp stool DNA kit (Tiangen)16S rRNA gene sequencingV3, V4, 338 F/806 RNrnr, nrGreengenes 13_8N/AMice with colitis receiving MT (n = 16) ± hyaluronic acid compared to mice with colitis without MT (n = 8)• Higher richness and diversity (number of OTUs, Shannon index)• Higher relative abundance of Bacillota• Higher relative abundance of Lactobacillus, lower relative abundance of Bacteroides, Blautia, and StreptococcusMice with colitis receiving MT (n = 16) ± hyaluronic acid compared to mice with colitis without MT (n = 8)• Improvement of colitis symptoms, decreased colon weight/length ratio, decreased spleen size, alleviation of damaged intestinal barrier, decreased colon inflammation (more uniform crypt structure and decreased inflammatory cell infiltration)• Higher expression of intestinal tight junction proteins in colon (occluding, zonula occludens-1),Zhao et al.141Mice with oxazolone-induced colitisChina20226 to 8w-old male C57BL/6 mice, nrLight conditions nr9 3% oxazolone (4.5 uL/g) injected into colon9 MT (50 mg/kg/d) orally for 7 d before 3% oxazolone (4.5 uL/g) injected into colonStoolEZNA soil kit (Omega Bio-Tek)16S rRNA gene sequencingV3, V4, 338 F, 806 RMiSeq 2500 (Illumina)nr, nrnrN/AMice with colitis receiving MT (n = 6) compared with mice with colitis without MT (n = 6)• Lower richness and diversity (ACE, Chao, and Shannon indices)• Higher relative abundances of Verrucomicrobiota and Actinomycetota• Lower relative abundance of Lachnospiraceae and Peptococcaceae• Higher relative abundances of Bifidobacterium and lower relative abundances of DesulfovibrioMice with colitis receiving MT (n = 9) compared with mice with colitis without MT (n = 9)• Higher body weight, less colon shortening, and lower histological pathology score in colon• Lower levels of neutrophils, TNF-α, IL-1ß, IL-5, and IL-13 in colon• Higher expression of tight junction proteins (occludin, zonula occludens-1) in colonLin et al.142Mice exposed to restraint stressChina20218w-old male IRC mice, standard diet14 h light/10 h dark cycles12 restraint for 3 d12 restraint and MT (20 mg/kg/d) intraperitoneally for 3 d12 MT (20 mg/kg/d) intraperitoneally for 3 d12 controlsColon contentDNeasy PowerSoil Kit (Qiagen)16S rRNA gene sequencingV3, V4, 338 F, 806 RHiSeq 2500 (Illumina)2×250, mean 79,928 reads/sampleRibosomal Database ProjectKEGGMice exposed to restraint stress receiving MT (n = 5) compared with mice exposed to restraint stress without MT (n = 5)• No difference in richness and diversity (number of OTUs, ACE, Chao1, Shannon, and Simpson indices)• Lower relative abundances of Bacteroides and Tyzzerella, and higher relative abundance of Mucispirillum, Oscillibacter, and Peptococcus• Higher relative abundance of microbiotas involved in tryptophan metabolism, benzoate degradation and synthesis and degradation of ketone body pathways, and lower relative abundance of microbiotas involved in alanine, aspartate and glutamate metabolism, glutamate metabolism, GABAergic synapses and central carbon metabolism in cancer pathwaysMice exposed to restraint stress receiving MT compared (n = 12) with mice exposed to restraint stress without MT (n = 12)• Higher corticosterone levels, lower MT levels, and higher reactive oxygens species plasma• Lower expression of TLR2, TLR4, p-p65, and p-IκB in colonRong et al.151Mice with jetlagChina20218w-old male C57BL/6 mice, standard diet12 h light/12 h dark cycles (or specific cycles to induce jetlag)6 jetlag6 jet lag and MT (0.4 mg/mL) in drinking water6 MT (0.4 mg/mL) in drinking water6 controlsStoolnr16S rRNA gene sequencingV3, V4, nrMiSeq (Illumina)nr, nrnrN/AJet-lagged mice receiving MT (n = 6) compared with jet-lagged mice without MT (n = 6)• Lower diversity (Shannon index), no difference in Simpson index• Lower relative abundance of Enterobacteriales• Higher relative abundance of A. muciniphilaJet-lagged mice receiving MT (n = 6) compared with jet-lagged mice without MT (n = 6)• Lower body weight and lipid intake• Lower lipid accumulation in ileum• Lower epididymal white adipose tissue around epididymis• Lower lipopolysaccharides in serum• Lower expression of TLR4, MyD88, and nuclear factor interleuktin-3-regualted protein in ileum• Restored circadian amplitude of nuclear receptor subfamily 1 group D member 1 and nuclear factor interleuktin-3-regualted protein• Lower TLR4/IL-22/STAT3 signalling pathway activity and higher angiopoietin-like 4 levels in ileumZhang et al.150Mice exposed to ochratoxin AChina20216w-old male C57BL/6 mice, standard diet12 h light/12 h dark cycles15 ochratoxin A (250 ug/kg/d) orally for 3w15 ochratoxin A (250 ug/kg/d) and MT (15 mg/kg/d) orally for 3w15 controls15 antibiotics (vancomycin 0.5 g/L,ampicillin 1 g/L, gentamicin 1 g/L, and streptomycin 1 g/L) orally for 3w15 antibiotics (vancomycin 0.5 g/L,ampicillin 1 g/L, gentamicin 1 g/L, and streptomycin 1 g/L) and ochratoxin A (250 ug/kg/d) orally for 3w15 antibiotics (vancomycin 0.5 g/L,ampicillin 1 g/L, gentamicin 1 g/L, and streptomycin 1 g/L), ochratoxin A and MT (15 mg/kg/d) (250 ug/kg/d) orally for 3wColon contentnr16S rRNA gene sequencingV3, V4, nrMiSeq (Illumina)nr, nrnrN/AOchratoxin A-exposed mice receiving MT (n = 8) compared with ochratoxin A-exposed mice without MT (n = 8) (not in antibiotic treated mice)• Higher richness and diversity (ACE, Chao1, Shannon, and Simpson indices)• Higher relative abundance of Bacteroidetes, and lower relative abundance of Bacillota• Lower relative abundance of Erysipelotrichales, and higher relative abundances of Bacteroidales and Clostridiales• Lower relative abundances of Lactobacillus and Desulfovibrio, and higher relative abundance of BacteroidesOchratoxin A-exposed mice receiving MT (n = 15) compared with ochratoxin A-exposed mice without MT (n = 15) (not in antibiotic-treated mice)• Higher weight gain and feed intake• Lower liver to body weight ratio• Lower levels of alkaline phosphatase, gamma-glutamyl transferase, low-density lipoprotein, and triglycerides, and higher levels of total protein, albumin, creatinine kinase in serum• Higer levels of antioxidant enzyme activities and lower levels of maleic dialdehyde in liver• Lower levels of TNF-α, IL-6, IL-1ß, and lipopolysaccharides in liver and ileum• Lower levels of reactive oxygen species, and apoptotic and necrotic cells in liver• Higher mitochondrial membrane potential and adenosine triphosphate in liver• Higher levels of short-chain fatty acids, lower levels of lipopolysaccharides in colon• Restored ileal morphology and permeability (disrupted by ochratoxin A)• Restored protein-expression related to apoptosis, autophagy, antioxidants, inflammation and tight junctions in liver (disrupted by ochratoxin A)• Restored ileum permeability (disrupted by ochratoxin A)Gao et al.109Mice with sleep deprivationChina2020Adult male ICR-CD1 mice, standard diet14 h light/10 h dark cycles5 sleep-deprived for 3 d5 sleep-deprived and MT (20 mg/kg/d) intraperitoneally for 3 d5 sleep-deprived and MT (40 mg/kg/d) intraperitoneally for 3 d5 controlsJejunal contentQIAamp DNA Stool Mini Kit (Qiagen)16S rRNA gene sequencingV3, V4, composite specific primersMiSeq (Illumina)nr, mean 75,221 reads/samplenrKEGGSleep-deprived mice receiving MT (n = 10) compared with sleep-deprived mice without MT (n = 5)• Higher richness and diversity (number of OTUs, ACE, Chao1, and Shannon indices), lower Simpson index• Higher relative abundance of Bacillota, and lower relative abundance of Bacteroidetes• Higher relative abundances of Bacteroidacea and Prevotellaceae, and lower relative abundances of Moraxellaceae and Aeromonadaceae• Lower abundance of pathways of cell wall/membrane/envelope biogenesis, energy production and conversion, replication, recombination and repair and translation, ribosomal structure and biogenesis, and higher abundance of pathway of carbohydrate transport and metabolism and transcriptionSleep-deprived mice receiving MT (n = 10) compared with sleep-deprived mice without MT (n = 5)• Lower cortisol levels in plasma• Higher levels of IL-22, and lower levels of IL-17 and reactive oxygen species in jejunumKim et al.143Mice with DSS-induced colitisChina20208 to 9w-old male BALB/c and WT/TLR4 KO mice, standard diet14 h light/10 h dark cyclesBALB/c:10 2.5%-DSS in drinking water for 6 d10 2.5%-DSS in drinking water plus MT (10 mg/kg/d) intraperitoneally for 8 d10 MT (10 mg/kg/d) intraperitoneally for 8 d10 controlsTLR KO:10 2.5%-DSS in drinking water for 6 d10 2.5%-DSS in drinking water plus MT (10 mg/kg/d) intraperitoneally for 8 d10 MT (10 mg/kg/d) intraperitoneally for 8 d10 controlsStoolFastDNA Spin Kit for Soil (MP Biomedicals)16S rRNA gene sequencingV3, V4, nrnrnr, nrEzTaxon-eN/AMice with colitis receiving MT (n = 5) compared with mice with colitis without MT (n = 5)• Higher richness (Chao index)• Lower relative abundance of Pseudomonadota, trend towards higher relative abundance of Bacillota, and trend towards lower relative abundance of Bacteroidetes• Higher relative abundance of RuminococcaceaeMice with colitis receiving MT (n = 10) compared with mice with colitis without MT (n = 10) (not in TLR4-knock-out mice)• Less colitis symptoms (lower disease activity index)• Lower histological pathology score in colon• Higher number of goblet cells in colon• Less colon shortening• Higher number of goblet cells in colon• Lower levels of IL-1ß, IL-17α, and higher levels of MT receptors and regenerating islet-derived protein 3-ß in colon• Higher expression of MT receptors in colonPark et al.144Mice with sleep deprivation exposed to water stressKorea20209w-old male C57BL/6 mice, standard diet12 h light/12 h dark cycles6 exposed to water stress for 10 d6 exposed to water stress and MT (10 mg/kg/d) intraperitoneally for 10 d6 exposed to water stress and sleep-deprived for 10 d6 exposed to water stress, sleep-deprived and MT (10 mg/kg/d) intraperitoneally for 10 d6 controlsStool samplesnr16S rRNA gene sequencingV3, V4, 341 F, 805 RMiSeq (Illumina)EzTaxon-eMice exposed to water stress ± sleep-deprivation receiving MT (n = 6) compared with mice exposed to water stress ± sleep-deprivation without MT (n = 12)• No difference in richness or diversity (number of OTUs, Shannon, and Simpson indices)• Lower relative abundances of Erysipelotrichaceae• Higher relative abundances of Lactobacillus• Higher relative A. muciniphila, and lower relative abundances of P. massiliensisMice exposed to water stress ± sleep-deprivation ± MT (n = 24) compared with controls (n = 6)• Lower weight, no difference in colon length or inflammationGao et al.108Mice with sleep deprivationChina20198w-old male CD1 mice, standard diet14 h light/10 h dark cycles24 sleep-deprived for 3 d24 sleep-deprived and MT (20 mg/kg/d) intraperitoneally for 3 d24 sleep-deprived and MT (40 mg/kg/d) intraperitoneally for 3 d24 controlsColon contentQIAamp DNA Stool Mini Kit (Qiagen)16S rRNA gene sequencingV3, V4, nrMiSeq (Illumina)nr, mean 74,133 reads/samplenrSleep-deprived mice receiving MT (n = 10) compared with sleep-deprived mice without MT (n = 5)• Higher richness (number of OTUs, ACE, Chao1, and Shannon indices), lower Simpson index• Lower relative abundance of Bacillota, and higher relative abundance of Bacteroidetes• Higher relative abundance of Akkermansia, Bacteroides, and Faecalibacterium, and lower relative abundance of AeromonasSleep-deprived mice receiving MT (n = 24) compared with sleep-deprived mice without MT (n = 24)• Lower norepinephrine levels in plasma• Higher levels of anti-inflammatory (IL-5, IL-10, and IFN-y) and lower levels of pro-inflammatory cytokines (TNF-α, IL-1ß, and IL-6) in plasma• Higher levels of antioxidant enzymes (glutathione peroxidase, superoxide dismutase, and catalase), lower total antioxidant capacity, and lower malondialdehyde levels (lipid peroxidation) in colon• Higher number of goblet cells, proliferation cell nuclear antigen-positive cells, mucin 2 expression, and tight junction protein expression (claudin-1, occluding, zonula occludens-1) in colonJing et al.145Mice with spinal cord injuryChina2019Adult female C57BL/6 mice, standard diet12 h light/12 h dark cycles16 spinal cord injury16 spinal cord injury and MT (10 mg/kg twice daily) intraperitoneally for 4w16 MT (10 mg/kg twice daily) intraperitoneally for 4w16 controls6 antibiotics (ampicillin 0.2 g/L, neomycin 0.2 g/L, metronidazole 0.2 g/L, vancomycin 0.1 g/L) 2w before and 4w after spinal cord injury6 antibiotics (ampicillin 0.2 g/L, neomycin 0.2 g/L, metronidazole 0.2 g/L, vancomycin 0.1 g/L) 2w before and 4w after spinal cord injury and MT 10 mg/kg twice daily intraperitoneal 4wStool samplesE.Z.N.A. Stool DNA Kit (Omega Bio-Tek)16S rRNA gene sequencingV3, V4, 338 F, 806 RMiSeq (Illumina)2×300, mean 33,999 reads/sampleSILVA (SSU128)N/ACultureColumbia blood agar, 38°C, 48 hMice with spinal cord injury receiving MT (n = 5) compared with mice with spinal cord injury without MT (n = 5)• Lower richness and diversity (ACE and Shannon indices)• Lower relative abundance of Clostridiales, higher relative abundance of Lactobacillales (Lactobacillus)Mice receiving MT (n = 5) compared with controls without spinal injury or MT (n = 5)• No difference in microbiota compositionMice with spinal cord injury receiving MT (n = 16) compared with mice with spinal cord injury without MT (n = 16)• Higer intestinal barrier integrity (tight junctions) and intestinal motility, reduced expression levels of proinflammatory cytokines (IL-17, IFNy, and monocyte chemoattractant protein-1)• Improved weight gain and metabolic profiling• Promoted locomotor recoveryMice with spinal cord injury without MT (n = 16) compared with controls without spinal injury or MT (n = 16)• Lower levels of MT in colonic tissue• Increased intestinal permeabilityYin et al.146Mice on high-fat dietChina2018Adult female ICR mice, standard or high-fat diet12 h light/12 h dark cycles10 high-fat diet for 2w10 high-fat diet and MT (0.4 mg/mL) in drinking water ( = approximately 108 mg/kg/d) for 2w10 controlsStool samplesnr16S rRNA gene sequencingV3, V4,MiSeq (Illumina)nr, mean 72,497 reads/sampleSILVAKEGGMice on high-fat diet receiving MT (n = 8) compared with mice on high-fat diet without MT (n = 8)• Higher diversity (Shannon and Simpson indices), no difference in richness (number of OTUs)• Lower relative abundance of Bacillota, and higher relative abundance of Bacteroidetes• Lower relative abundances of Lactobacillales, and higher relative abundances of Bacteroidales, Erysipelotrichales, and Burkholderiales• Lower relative abundances of Lactobacillus, Bacteroides, Alistipes, and Parasutterella• Higher metabolism of amino acid, energy, and cofactors and vitamins, lower membrane transport and carbohydrate metabolism, and lower relative abundance of lipid metabolism-related genesMice on high-fat diet receiving MT (n = 10) compared with mice on high-fat diet without MT (n = 10)• Lower weight of subcutaneous adipose tissue• Lower lipid accumulation in liver• Lower levels of triglycerides in serum• Higher mRNA expression of peroxisome proliferator-activated receptor alpha and liver X receptor beta, and lower mRNA expression of sterol regulatory element-binding protein 2 in subcutaneous adipose tissue• Higher mRNA expression of peroxisome proliferator-activated receptor alpha, liver X receptor beta, and acetyl-coenzyme A carboxylase in liverZhu et al.147Mice with DSS-induced colitisChina20188w-old ICR mice, standard diet12 h light/12 h dark cycles10 5%-DSS in drinking water for 1w10 5%-DSS and MT (0.2 mg/L) in drinking water for 1wColon contentnr16S rRNA gene sequencingV3, V4, 515 F, 907 RMiSeq (Illumina)2×250, mean 8,198 reads/sampleSILVA (SSU115)N/AMice with colitis receiving MT (n = 10) compared with mice with colitis without MT (n = 10)• No difference in richness or diversity (ACE, Chao1, Shannon, and Simpson indices)• Higher relative abundance of Bacillota, and lower relative abundance of Bacteroidetes• Higher relative abundances of Coprococcus_1 and Ruminococcaceae_UCG-014Mice with colitis receiving MT (n = 10) compared with mice with colitis without MT (n = 10)• Higher antioxidant capability in plasma (measured by 2,2’-azino-bis3-ethylbenz-thiazoline-6-sulfonic acid radical cation decolorization assay)Ren et al.148Weanling miceChina20173w-old male ICR mice, standard diet12 h light/12 h dark cycles10 MT (0.2 g/L) in drinking water for 2w10 controls10 antibiotics (streptomycin 1 g/L, ampicillin 1 g/L, gentamicin 1 g/L, and vancomycin 0.5 g/L) orally for 2w10 antibiotics (streptomycin 1 g/L, ampicillin 1 g/L, gentamicin 1 g/L, and vancomycin 0.5 g/L) and MT (0.2 g/L) orally for 2w10 germ-free mice10 germ-free mice receiving MT (0.2 g/L) orally for 2wStool samplesQIAamp DNA Stool Mini Kit (Qiagen)16S rRNA gene sequencingV3, V4, 338 F, 806 RMiSeq (Illumina)2×250, nrSILVAKEGGMice receiving MT (n = 8) compared with controls without MT (n = 8)• Higher richness (number of OTUs, ACE, and Chao1 indices)• Lower relative abundances of Bacteroidetes• Lower relative abundance of Bacteroidales• Lower relative abundance Prevotellaceae• Higher relative abundance of Lactobacillus (L. intestinalis, L. johnsonii, and L. reuteri)• Altered microbial metabolism, including amino acid metabolism, polycyclic aromatic hydrocarbon degradation, degradation of aromatic compounds and drug metabolism (4-aminobenzoic acid, 2-indanone, p-cresol, malonamide, saccharic acid, 4-hydroxybenzoic acid, threitol, 7,8-dimethylalloxazine, 6-hydroxy caproic acid dimer, 6-methylmercaptopurine, 5′-methylthioadenosine, palatinitol, cis-2- hydroxycinnamic acid, 2-carboxybenzaldehyde, and saccharopine)Mice receiving MT (n = 10) compared with controls without MT (n = 10)• Higher weight gain (not in antibiotic-treated or germ-free mice)• Improved intestinal morphology (villus length, crypt depth, villus to crypt ratio) (not in antibiotic-treated or germ-free mice)• Lower bacterial load in mice infected with enterotoxigenic E. coli (not in antibiotic-treated mice)Xu et al.149Mice on high-fat dietChina201710w-old male C57BL/6 J mice, standard diet or high-fat diet12 h light/12 h dark cycles5 high-fat diet for 10w5 high-fat diet plus MT (50 mg/kg/d) orally for 10w5 controlsStool samplesQIAamp DNA Stool Mini Kit (Qiagen)16S rRNA gene sequencingV3, V4, composite specific bacterial primersMiSeq (Illumina)nr, mean 60,983 reads/samplenrN/AMice on high-fat diet receiving MT (n = 5) compared with mice on high-fat diet without MT (n = 5) or mice on standard diet without MT (n = 5)• Lower richness and diversity (lower number of OTUs, lower ACE, Chao1, and Shannon indices), higher Simpson index• Lower relative abundance of Bacillota, higher relative abundance of Bacteroidetes and higher relative abundance of Verrucomicrobiota• Lower relative abundance of Desulfovibrionaceae (only compared with mice without MT on high-fat diet)• Higher relative abundance of Akkermansia and lower relative abundaunce of Alstipes, Anaerotruncus, and Helicobacter_marmotae (only compared with mice without MT on high-fat diet)Mice on high-fat diet receiving MT (n = 5) compared with mice on high-fat diet without MT (n = 5) Decreased weight gain, liver steatosis, insulin resistance and low-grade inflammationACE – abundance-based coverage estimatorNF-κB – nuclear factor-kappa BC57BL/6 – C57 Black 6nr – not reportedd – daysMyD88 - myeloid differentiation primary response gene 88DSS - DSSOTU – operational taxonomic unith – hourp-p65 – phosphorylated p65ICR – institute of cancer researchp-IκB – phosphorylated inhibitor of kappa BIFN – interferonSTAT3 - signal transducer and activator of transcription 3IL – interleukinTLR – toll-like receptorKEGG – Kyoto encyclopedia of genes and genomesTNF-α – tumor necrosis factor alphamRNA – messenger ribonucleic nucleic acidw – weekN/A – not applicableWT/TLR4 KO mice – wild-Type/Toll-Like Receptor 4 Knockout mice Summary of findings of studies investigating the effect of MT on the composition and function of the intestinal microbiota Liu et al.139 Mice exposed to aflatoxin B1 China 2022 6w-old male C57BL/6 mice, standard diet Light conditions nr 2 alfatoxin B1 (0.75 ng/kg/d) orally for 2w 2 alfatoxin B1 (0.75 ng/kg/d) and MT (20 mg/kg/d) orally for 2w 2 alfatoxin B1 (0.75 ng/kg/d), MT (20 mg/kg/d) and glycine-betaine-muricholic acid (10 mg/kg/d) orally for 2w 2 controls Colon content DNeasy PowerSoil Kit (Qiagen) 16S rRNA gene sequencing V3, V4, nr nr nr, nr nr N/A Alfatoxin B1-exposed mice receiving MT (n = 2) compared with alfatoxin B1-exposed mice without MT (n = 2) • Higher richness and diversity (number of OTUs, ACE, Chao, Shannon, and Simpson indices) • Lower relative abundance of Bacillota, and higher relative abundance of Bacteroidetes • Lower relative abundances of Clostridiales and Lactobacillales • Lower relative abundances of Desulfovibrio, Clostridium_XIVa, and Lactobacillus Alfatoxin B1-exposed mice receiving MT (n = 2) compared with alfatoxin B1-exposed mice without MT (n = 2) • Higher expression of intestinal tight junction proteins (claudin-1, occluding, zonula occludens-1), and lower intestinal permeability in ileum • Lower levels of lipopolysaccharides in serum and liver (not in antibiotic-treated mice) • Higher levels of farnesoid X receptor protein and lower levels TLR4/NF-κB signalling pathway-related mRNA, as well as lower expression of TLR4, MyD88, p-p65, and p-IκB in ileum (not in mice treated with glycine-betaine-muricholic acid) Jing et al.140 Mice with DSS-induced colitis China 2022 6 to 8w-old male C57BL/6 mice, standard diet Light conditions nr 8 3%-DSS in drinking water for 7 d 8 3%-DSS in drinking water for 7 d followed by 5-aminosalicylic acid (50 mg/kg/d) 8 3%-DSS in drinking water for 7 d followed by hyaluronic acid orally for 7 d 8 3%-DSS in drinking water for 7 d followed by MT orally for 7 d 8 3%-DSS in drinking water for 7 d followed by hyaluronic acid and MT orally for 7 d 8 controls Stool Tianamp stool DNA kit (Tiangen) 16S rRNA gene sequencing V3, V4, 338 F/806 R Nr nr, nr Greengenes 13_8 N/A Mice with colitis receiving MT (n = 16) ± hyaluronic acid compared to mice with colitis without MT (n = 8) • Higher richness and diversity (number of OTUs, Shannon index) • Higher relative abundance of Bacillota • Higher relative abundance of Lactobacillus, lower relative abundance of Bacteroides, Blautia, and Streptococcus Mice with colitis receiving MT (n = 16) ± hyaluronic acid compared to mice with colitis without MT (n = 8) • Improvement of colitis symptoms, decreased colon weight/length ratio, decreased spleen size, alleviation of damaged intestinal barrier, decreased colon inflammation (more uniform crypt structure and decreased inflammatory cell infiltration) • Higher expression of intestinal tight junction proteins in colon (occluding, zonula occludens-1), Zhao et al.141 Mice with oxazolone-induced colitis China 2022 6 to 8w-old male C57BL/6 mice, nr Light conditions nr 9 3% oxazolone (4.5 uL/g) injected into colon 9 MT (50 mg/kg/d) orally for 7 d before 3% oxazolone (4.5 uL/g) injected into colon Stool EZNA soil kit (Omega Bio-Tek) 16S rRNA gene sequencing V3, V4, 338 F, 806 R MiSeq 2500 (Illumina) nr, nr nr N/A Mice with colitis receiving MT (n = 6) compared with mice with colitis without MT (n = 6) • Lower richness and diversity (ACE, Chao, and Shannon indices) • Higher relative abundances of Verrucomicrobiota and Actinomycetota • Lower relative abundance of Lachnospiraceae and Peptococcaceae • Higher relative abundances of Bifidobacterium and lower relative abundances of Desulfovibrio Mice with colitis receiving MT (n = 9) compared with mice with colitis without MT (n = 9) • Higher body weight, less colon shortening, and lower histological pathology score in colon • Lower levels of neutrophils, TNF-α, IL-1ß, IL-5, and IL-13 in colon • Higher expression of tight junction proteins (occludin, zonula occludens-1) in colon Lin et al.142 Mice exposed to restraint stress China 2021 8w-old male IRC mice, standard diet 14 h light/10 h dark cycles 12 restraint for 3 d 12 restraint and MT (20 mg/kg/d) intraperitoneally for 3 d 12 MT (20 mg/kg/d) intraperitoneally for 3 d 12 controls Colon content DNeasy PowerSoil Kit (Qiagen) 16S rRNA gene sequencing V3, V4, 338 F, 806 R HiSeq 2500 (Illumina) 2×250, mean 79,928 reads/sample Ribosomal Database Project KEGG Mice exposed to restraint stress receiving MT (n = 5) compared with mice exposed to restraint stress without MT (n = 5) • No difference in richness and diversity (number of OTUs, ACE, Chao1, Shannon, and Simpson indices) • Lower relative abundances of Bacteroides and Tyzzerella, and higher relative abundance of Mucispirillum, Oscillibacter, and Peptococcus • Higher relative abundance of microbiotas involved in tryptophan metabolism, benzoate degradation and synthesis and degradation of ketone body pathways, and lower relative abundance of microbiotas involved in alanine, aspartate and glutamate metabolism, glutamate metabolism, GABAergic synapses and central carbon metabolism in cancer pathways Mice exposed to restraint stress receiving MT compared (n = 12) with mice exposed to restraint stress without MT (n = 12) • Higher corticosterone levels, lower MT levels, and higher reactive oxygens species plasma • Lower expression of TLR2, TLR4, p-p65, and p-IκB in colon Rong et al.151 Mice with jetlag China 2021 8w-old male C57BL/6 mice, standard diet 12 h light/12 h dark cycles (or specific cycles to induce jetlag) 6 jetlag 6 jet lag and MT (0.4 mg/mL) in drinking water 6 MT (0.4 mg/mL) in drinking water 6 controls Stool nr 16S rRNA gene sequencing V3, V4, nr MiSeq (Illumina) nr, nr nr N/A Jet-lagged mice receiving MT (n = 6) compared with jet-lagged mice without MT (n = 6) • Lower diversity (Shannon index), no difference in Simpson index • Lower relative abundance of Enterobacteriales • Higher relative abundance of A. muciniphila Jet-lagged mice receiving MT (n = 6) compared with jet-lagged mice without MT (n = 6) • Lower body weight and lipid intake • Lower lipid accumulation in ileum • Lower epididymal white adipose tissue around epididymis • Lower lipopolysaccharides in serum • Lower expression of TLR4, MyD88, and nuclear factor interleuktin-3-regualted protein in ileum • Restored circadian amplitude of nuclear receptor subfamily 1 group D member 1 and nuclear factor interleuktin-3-regualted protein • Lower TLR4/IL-22/STAT3 signalling pathway activity and higher angiopoietin-like 4 levels in ileum Zhang et al.150 Mice exposed to ochratoxin A China 2021 6w-old male C57BL/6 mice, standard diet 12 h light/12 h dark cycles 15 ochratoxin A (250 ug/kg/d) orally for 3w 15 ochratoxin A (250 ug/kg/d) and MT (15 mg/kg/d) orally for 3w 15 controls 15 antibiotics (vancomycin 0.5 g/L, ampicillin 1 g/L, gentamicin 1 g/L, and streptomycin 1 g/L) orally for 3w 15 antibiotics (vancomycin 0.5 g/L, ampicillin 1 g/L, gentamicin 1 g/L, and streptomycin 1 g/L) and ochratoxin A (250 ug/kg/d) orally for 3w 15 antibiotics (vancomycin 0.5 g/L, ampicillin 1 g/L, gentamicin 1 g/L, and streptomycin 1 g/L), ochratoxin A and MT (15 mg/kg/d) (250 ug/kg/d) orally for 3w Colon content nr 16S rRNA gene sequencing V3, V4, nr MiSeq (Illumina) nr, nr nr N/A Ochratoxin A-exposed mice receiving MT (n = 8) compared with ochratoxin A-exposed mice without MT (n = 8) (not in antibiotic treated mice) • Higher richness and diversity (ACE, Chao1, Shannon, and Simpson indices) • Higher relative abundance of Bacteroidetes, and lower relative abundance of Bacillota • Lower relative abundance of Erysipelotrichales, and higher relative abundances of Bacteroidales and Clostridiales • Lower relative abundances of Lactobacillus and Desulfovibrio, and higher relative abundance of Bacteroides Ochratoxin A-exposed mice receiving MT (n = 15) compared with ochratoxin A-exposed mice without MT (n = 15) (not in antibiotic-treated mice) • Higher weight gain and feed intake • Lower liver to body weight ratio • Lower levels of alkaline phosphatase, gamma-glutamyl transferase, low-density lipoprotein, and triglycerides, and higher levels of total protein, albumin, creatinine kinase in serum • Higer levels of antioxidant enzyme activities and lower levels of maleic dialdehyde in liver • Lower levels of TNF-α, IL-6, IL-1ß, and lipopolysaccharides in liver and ileum • Lower levels of reactive oxygen species, and apoptotic and necrotic cells in liver • Higher mitochondrial membrane potential and adenosine triphosphate in liver • Higher levels of short-chain fatty acids, lower levels of lipopolysaccharides in colon • Restored ileal morphology and permeability (disrupted by ochratoxin A) • Restored protein-expression related to apoptosis, autophagy, antioxidants, inflammation and tight junctions in liver (disrupted by ochratoxin A) • Restored ileum permeability (disrupted by ochratoxin A) Gao et al.109 Mice with sleep deprivation China 2020 Adult male ICR-CD1 mice, standard diet 14 h light/10 h dark cycles 5 sleep-deprived for 3 d 5 sleep-deprived and MT (20 mg/kg/d) intraperitoneally for 3 d 5 sleep-deprived and MT (40 mg/kg/d) intraperitoneally for 3 d 5 controls Jejunal content QIAamp DNA Stool Mini Kit (Qiagen) 16S rRNA gene sequencing V3, V4, composite specific primers MiSeq (Illumina) nr, mean 75,221 reads/sample nr KEGG Sleep-deprived mice receiving MT (n = 10) compared with sleep-deprived mice without MT (n = 5) • Higher richness and diversity (number of OTUs, ACE, Chao1, and Shannon indices), lower Simpson index • Higher relative abundance of Bacillota, and lower relative abundance of Bacteroidetes • Higher relative abundances of Bacteroidacea and Prevotellaceae, and lower relative abundances of Moraxellaceae and Aeromonadaceae • Lower abundance of pathways of cell wall/membrane/envelope biogenesis, energy production and conversion, replication, recombination and repair and translation, ribosomal structure and biogenesis, and higher abundance of pathway of carbohydrate transport and metabolism and transcription Sleep-deprived mice receiving MT (n = 10) compared with sleep-deprived mice without MT (n = 5) • Lower cortisol levels in plasma • Higher levels of IL-22, and lower levels of IL-17 and reactive oxygen species in jejunum Kim et al.143 Mice with DSS-induced colitis China 2020 8 to 9w-old male BALB/c and WT/TLR4 KO mice, standard diet 14 h light/10 h dark cycles BALB/c: 10 2.5%-DSS in drinking water for 6 d 10 2.5%-DSS in drinking water plus MT (10 mg/kg/d) intraperitoneally for 8 d 10 MT (10 mg/kg/d) intraperitoneally for 8 d 10 controls TLR KO: 10 2.5%-DSS in drinking water for 6 d 10 2.5%-DSS in drinking water plus MT (10 mg/kg/d) intraperitoneally for 8 d 10 MT (10 mg/kg/d) intraperitoneally for 8 d 10 controls Stool FastDNA Spin Kit for Soil (MP Biomedicals) 16S rRNA gene sequencing V3, V4, nr nr nr, nr EzTaxon-e N/A Mice with colitis receiving MT (n = 5) compared with mice with colitis without MT (n = 5) • Higher richness (Chao index) • Lower relative abundance of Pseudomonadota, trend towards higher relative abundance of Bacillota, and trend towards lower relative abundance of Bacteroidetes • Higher relative abundance of Ruminococcaceae Mice with colitis receiving MT (n = 10) compared with mice with colitis without MT (n = 10) (not in TLR4-knock-out mice) • Less colitis symptoms (lower disease activity index) • Lower histological pathology score in colon • Higher number of goblet cells in colon • Less colon shortening • Higher number of goblet cells in colon • Lower levels of IL-1ß, IL-17α, and higher levels of MT receptors and regenerating islet-derived protein 3-ß in colon • Higher expression of MT receptors in colon Park et al.144 Mice with sleep deprivation exposed to water stress Korea 2020 9w-old male C57BL/6 mice, standard diet 12 h light/12 h dark cycles 6 exposed to water stress for 10 d 6 exposed to water stress and MT (10 mg/kg/d) intraperitoneally for 10 d 6 exposed to water stress and sleep-deprived for 10 d 6 exposed to water stress, sleep-deprived and MT (10 mg/kg/d) intraperitoneally for 10 d 6 controls Stool samples nr 16S rRNA gene sequencing V3, V4, 341 F, 805 R MiSeq (Illumina) EzTaxon-e Mice exposed to water stress ± sleep-deprivation receiving MT (n = 6) compared with mice exposed to water stress ± sleep-deprivation without MT (n = 12) • No difference in richness or diversity (number of OTUs, Shannon, and Simpson indices) • Lower relative abundances of Erysipelotrichaceae • Higher relative abundances of Lactobacillus • Higher relative A. muciniphila, and lower relative abundances of P. massiliensis Mice exposed to water stress ± sleep-deprivation ± MT (n = 24) compared with controls (n = 6) • Lower weight, no difference in colon length or inflammation Gao et al.108 Mice with sleep deprivation China 2019 8w-old male CD1 mice, standard diet 14 h light/10 h dark cycles 24 sleep-deprived for 3 d 24 sleep-deprived and MT (20 mg/kg/d) intraperitoneally for 3 d 24 sleep-deprived and MT (40 mg/kg/d) intraperitoneally for 3 d 24 controls Colon content QIAamp DNA Stool Mini Kit (Qiagen) 16S rRNA gene sequencing V3, V4, nr MiSeq (Illumina) nr, mean 74,133 reads/sample nr Sleep-deprived mice receiving MT (n = 10) compared with sleep-deprived mice without MT (n = 5) • Higher richness (number of OTUs, ACE, Chao1, and Shannon indices), lower Simpson index • Lower relative abundance of Bacillota, and higher relative abundance of Bacteroidetes • Higher relative abundance of Akkermansia, Bacteroides, and Faecalibacterium, and lower relative abundance of Aeromonas Sleep-deprived mice receiving MT (n = 24) compared with sleep-deprived mice without MT (n = 24) • Lower norepinephrine levels in plasma • Higher levels of anti-inflammatory (IL-5, IL-10, and IFN-y) and lower levels of pro-inflammatory cytokines (TNF-α, IL-1ß, and IL-6) in plasma • Higher levels of antioxidant enzymes (glutathione peroxidase, superoxide dismutase, and catalase), lower total antioxidant capacity, and lower malondialdehyde levels (lipid peroxidation) in colon • Higher number of goblet cells, proliferation cell nuclear antigen-positive cells, mucin 2 expression, and tight junction protein expression (claudin-1, occluding, zonula occludens-1) in colon Jing et al.145 Mice with spinal cord injury China 2019 Adult female C57BL/6 mice, standard diet 12 h light/12 h dark cycles 16 spinal cord injury 16 spinal cord injury and MT (10 mg/kg twice daily) intraperitoneally for 4w 16 MT (10 mg/kg twice daily) intraperitoneally for 4w 16 controls 6 antibiotics (ampicillin 0.2 g/L, neomycin 0.2 g/L, metronidazole 0.2 g/L, vancomycin 0.1 g/L) 2w before and 4w after spinal cord injury 6 antibiotics (ampicillin 0.2 g/L, neomycin 0.2 g/L, metronidazole 0.2 g/L, vancomycin 0.1 g/L) 2w before and 4w after spinal cord injury and MT 10 mg/kg twice daily intraperitoneal 4w Stool samples E.Z.N.A. Stool DNA Kit (Omega Bio-Tek) 16S rRNA gene sequencing V3, V4, 338 F, 806 R MiSeq (Illumina) 2×300, mean 33,999 reads/sample SILVA (SSU128) N/A Culture Columbia blood agar, 38°C, 48 h Mice with spinal cord injury receiving MT (n = 5) compared with mice with spinal cord injury without MT (n = 5) • Lower richness and diversity (ACE and Shannon indices) • Lower relative abundance of Clostridiales, higher relative abundance of Lactobacillales (Lactobacillus) Mice receiving MT (n = 5) compared with controls without spinal injury or MT (n = 5) • No difference in microbiota composition Mice with spinal cord injury receiving MT (n = 16) compared with mice with spinal cord injury without MT (n = 16) • Higer intestinal barrier integrity (tight junctions) and intestinal motility, reduced expression levels of proinflammatory cytokines (IL-17, IFNy, and monocyte chemoattractant protein-1) • Improved weight gain and metabolic profiling • Promoted locomotor recovery Mice with spinal cord injury without MT (n = 16) compared with controls without spinal injury or MT (n = 16) • Lower levels of MT in colonic tissue • Increased intestinal permeability Yin et al.146 Mice on high-fat diet China 2018 Adult female ICR mice, standard or high-fat diet 12 h light/12 h dark cycles 10 high-fat diet for 2w 10 high-fat diet and MT (0.4 mg/mL) in drinking water ( = approximately 108 mg/kg/d) for 2w 10 controls Stool samples nr 16S rRNA gene sequencing V3, V4, MiSeq (Illumina) nr, mean 72,497 reads/sample SILVA KEGG Mice on high-fat diet receiving MT (n = 8) compared with mice on high-fat diet without MT (n = 8) • Higher diversity (Shannon and Simpson indices), no difference in richness (number of OTUs) • Lower relative abundance of Bacillota, and higher relative abundance of Bacteroidetes • Lower relative abundances of Lactobacillales, and higher relative abundances of Bacteroidales, Erysipelotrichales, and Burkholderiales • Lower relative abundances of Lactobacillus, Bacteroides, Alistipes, and Parasutterella • Higher metabolism of amino acid, energy, and cofactors and vitamins, lower membrane transport and carbohydrate metabolism, and lower relative abundance of lipid metabolism-related genes Mice on high-fat diet receiving MT (n = 10) compared with mice on high-fat diet without MT (n = 10) • Lower weight of subcutaneous adipose tissue • Lower lipid accumulation in liver • Lower levels of triglycerides in serum • Higher mRNA expression of peroxisome proliferator-activated receptor alpha and liver X receptor beta, and lower mRNA expression of sterol regulatory element-binding protein 2 in subcutaneous adipose tissue • Higher mRNA expression of peroxisome proliferator-activated receptor alpha, liver X receptor beta, and acetyl-coenzyme A carboxylase in liver Zhu et al.147 Mice with DSS-induced colitis China 2018 8w-old ICR mice, standard diet 12 h light/12 h dark cycles 10 5%-DSS in drinking water for 1w 10 5%-DSS and MT (0.2 mg/L) in drinking water for 1w Colon content nr 16S rRNA gene sequencing V3, V4, 515 F, 907 R MiSeq (Illumina) 2×250, mean 8,198 reads/sample SILVA (SSU115) N/A Mice with colitis receiving MT (n = 10) compared with mice with colitis without MT (n = 10) • No difference in richness or diversity (ACE, Chao1, Shannon, and Simpson indices) • Higher relative abundance of Bacillota, and lower relative abundance of Bacteroidetes • Higher relative abundances of Coprococcus_1 and Ruminococcaceae_UCG-014 Mice with colitis receiving MT (n = 10) compared with mice with colitis without MT (n = 10) • Higher antioxidant capability in plasma (measured by 2,2’-azino-bis3-ethylbenz-thiazoline-6-sulfonic acid radical cation decolorization assay) Ren et al.148 Weanling mice China 2017 3w-old male ICR mice, standard diet 12 h light/12 h dark cycles 10 MT (0.2 g/L) in drinking water for 2w 10 controls 10 antibiotics (streptomycin 1 g/L, ampicillin 1 g/L, gentamicin 1 g/L, and vancomycin 0.5 g/L) orally for 2w 10 antibiotics (streptomycin 1 g/L, ampicillin 1 g/L, gentamicin 1 g/L, and vancomycin 0.5 g/L) and MT (0.2 g/L) orally for 2w 10 germ-free mice 10 germ-free mice receiving MT (0.2 g/L) orally for 2w Stool samples QIAamp DNA Stool Mini Kit (Qiagen) 16S rRNA gene sequencing V3, V4, 338 F, 806 R MiSeq (Illumina) 2×250, nr SILVA KEGG Mice receiving MT (n = 8) compared with controls without MT (n = 8) • Higher richness (number of OTUs, ACE, and Chao1 indices) • Lower relative abundances of Bacteroidetes • Lower relative abundance of Bacteroidales • Lower relative abundance Prevotellaceae • Higher relative abundance of Lactobacillus (L. intestinalis, L. johnsonii, and L. reuteri) • Altered microbial metabolism, including amino acid metabolism, polycyclic aromatic hydrocarbon degradation, degradation of aromatic compounds and drug metabolism (4-aminobenzoic acid, 2-indanone, p-cresol, malonamide, saccharic acid, 4-hydroxybenzoic acid, threitol, 7,8-dimethylalloxazine, 6-hydroxy caproic acid dimer, 6-methylmercaptopurine, 5′-methylthioadenosine, palatinitol, cis-2- hydroxycinnamic acid, 2-carboxybenzaldehyde, and saccharopine) Mice receiving MT (n = 10) compared with controls without MT (n = 10) • Higher weight gain (not in antibiotic-treated or germ-free mice) • Improved intestinal morphology (villus length, crypt depth, villus to crypt ratio) (not in antibiotic-treated or germ-free mice) • Lower bacterial load in mice infected with enterotoxigenic E. coli (not in antibiotic-treated mice) Xu et al.149 Mice on high-fat diet China 2017 10w-old male C57BL/6 J mice, standard diet or high-fat diet 12 h light/12 h dark cycles 5 high-fat diet for 10w 5 high-fat diet plus MT (50 mg/kg/d) orally for 10w 5 controls Stool samples QIAamp DNA Stool Mini Kit (Qiagen) 16S rRNA gene sequencing V3, V4, composite specific bacterial primers MiSeq (Illumina) nr, mean 60,983 reads/sample nr N/A Mice on high-fat diet receiving MT (n = 5) compared with mice on high-fat diet without MT (n = 5) or mice on standard diet without MT (n = 5) • Lower richness and diversity (lower number of OTUs, lower ACE, Chao1, and Shannon indices), higher Simpson index • Lower relative abundance of Bacillota, higher relative abundance of Bacteroidetes and higher relative abundance of Verrucomicrobiota • Lower relative abundance of Desulfovibrionaceae (only compared with mice without MT on high-fat diet) • Higher relative abundance of Akkermansia and lower relative abundaunce of Alstipes, Anaerotruncus, and Helicobacter_marmotae (only compared with mice without MT on high-fat diet) ACE – abundance-based coverage estimatorNF-κB – nuclear factor-kappa B C57BL/6 – C57 Black 6nr – not reported d – daysMyD88 - myeloid differentiation primary response gene 88 DSS - DSSOTU – operational taxonomic unit h – hourp-p65 – phosphorylated p65 ICR – institute of cancer researchp-IκB – phosphorylated inhibitor of kappa B IFN – interferonSTAT3 - signal transducer and activator of transcription 3 IL – interleukinTLR – toll-like receptor KEGG – Kyoto encyclopedia of genes and genomesTNF-α – tumor necrosis factor alpha mRNA – messenger ribonucleic nucleic acidw – week N/A – not applicableWT/TLR4 KO mice – wild-Type/Toll-Like Receptor 4 Knockout mice Overall, 8 studies (57%) found a higher richness and/or diversity of the intestinal microbiota in mice who were given MT (orally n = 5, intraperitoneal n = 3)108,109,139,140,143,146,148,150, 4 (29%) a lower richness and/or diversity (orally n = 2, intraperitoneal n = 2)141,145,149,151 and 3 (21%) no difference in richness and diversity (orally n = 1, intraperitoneal n = 1, into colon n = 1)142,144,147. On the phylum level, 5 studies reported a lower relative abundance of Bacillota108,139,146,149,150 and higher relative abundance of Bacteroidota108,139,146,149,150 in mice who received MT139. In contrast, 3 studies each reported higher relative abundances of Bacillota109,140,147 and a lower relative abundances of Bacteroidetes109,147,148. Furthermore, 2 studies reported higher relative abundances of Verrucomicrobiota141,149, and one each a higher relative abundance of Actinomycetota141 and a lower relative abundance of Pseudomonadota143. On the order level, MT was associated with lower relative abundances of Enterobacteriales150,151 and Lactobacillales139,145,146, and higher relative abundances of Burkholderiales108 and Erysipelotrichales108. Inconsistent findings were reported for Clostridiales (lower139,145 and higher150) and Bacteroidales (higher108,150 and lower148). On the family level, MT was associated with level lower relative abundances of Aeromonadaceae109, Desulfovibrionaceae149, Erysipelotrichaceae144, Lachnospiraceae141, Moraxellaceae109, and Peptococcaceae141, and higher relative abundances of Bacteroidaceae109 and Ruminococcaceae143. Inconsistent findings were reported for Prevotellaceae109,148. On the genus level, MT was associated with lower relative abundances of Aeromonas108, Alistipes146,149, Anaerotruncus149, Clostridium_XIVa139, Coprococcus_1147, Desulfovibrio139,141,150, Helicobacter_marmotae149, Parasutterella108, Ruminococcaceae_UCG-014147, and Tyzzerella142, and higher relative abundances of Akkermansia108,149, Bifidobacterium141, Blautia140, Faecalibacterium108, Mucispirillum142, Oscillibacter142, Peptococcus142, and Streptococcus142. Inconsistent findings were reported for Bacteroides108,140,142,146,150 and Lactobacillus139,140,144–146,148,150. On the species level, MT was associated with a higher relative abundance of A. muciniphila144,151, L. intestinalis147, L. johnsonii147, and L. reuteri147 and lower relative abundance of Phocaeicola massiliensis (Fig. 2)144. Interestingly, antibiotics often suppressed the effects of exogenous MT on the intestinal microbiota150,151.Fig. 2Reported effects of melatonin on the composition of the intestinal microbiota in mice.Blue names/lines indicate a reported increase in abundance; red indicates a decrease; purple indicates both. Black names/lines are shown for clarity and have no reported effects in the literature. Note that all names are adjusted to reflect current taxonomic nomenclature at the time of writing and may not match how these are reported in older literature. Reported effects of melatonin on the composition of the intestinal microbiota in mice. Blue names/lines indicate a reported increase in abundance; red indicates a decrease; purple indicates both. Black names/lines are shown for clarity and have no reported effects in the literature. Note that all names are adjusted to reflect current taxonomic nomenclature at the time of writing and may not match how these are reported in older literature. MT has also been reported to alter metabolic pathways of the intestinal microbiota. For example, enhancement in pathways related to tryptophan metabolism, benzoate degradation, and synthesis/degradation of ketone bodies and impairment of pathways associated with alanine, aspartate, and glutamate metabolism, as well as pathways related to GABAergic synapses and central carbon metabolism in cancer pathways142. Furthermore, impairment of pathways involved in cell wall/membrane/envelope biogenesis, energy production, recombination, repair along with translation, and ribosomal structure biogenesis have been observed after MT supplementation143,148. Furthermore, enhancement of pathways involved in amino acids and cofactors/vitamins have been reported, while pathways involved in carbohydrate metabolism findings were inconsistent146,148. Effects of intestinal MT on the intestine, other organs, and diseases MT has multiple effects on the intestine through interactions with MT, serotonin, and cholecystokinin B receptors152, as well as receptor-independent processes. It inhibits the increase in gastrointestinal motility and smooth muscle cell contraction caused by serotonin153. In humans, MT has been shown to influence intestinal permeability47, while in rats, it has been reported to influence intestinal motility154–157, permeability155,156, bicarbonate secretion155,156, and the release of peptides involved in energy balance158, similar to observations in sheep159. In mice and rats with induced ulcerative colitis, MT decreases inflammation-associated mucosal injury by inhibiting NF-kB activation, regulating macrophages activity, and reducing chemokine expression, bacterial translocation, and apoptosis160–164. MT also protects rats from radiotherapy-induced small intestine toxicity165. In humans with ulcerative colitis or proctitis, increased numbers of enterochromaffin cells, elevated ASMT expression, and higher levels of 6-sulfatoxy MT in urine indicate enhanced MT secretion166,167. Similarly, increased MT secretion has been observed in patients with lymphocytic colitis168. There is only limited and indirect evidence from animal studies regarding how MT produced in the intestine affects other organs. One study in mice suggests that MT treatment improves cognitive function and intestinal histological findings following cerebral damage induced by intestinal ischemia and reperfusion169. Similarly, a study in rats showed that MT mitigates oxidative and nitrosative stress in both the intestine and the lung in response to mesenteric ischemia and reperfusion injury170. Another study in rats showed that MT exerts protective effects on the stomach and pancreas, preventing damage and promoting healing of gastric ulcers through antioxidant mechanisms and the activation of specific receptors171. Discussion MT and the intestinal microbiota have a complex functional interrelationship. Intestinal MT is derived from various potential sources, including food, enterochromaffin cells, and the microbiota itself (Fig. 1); however, the contributions from these sources to overall intestinal MT levels require further investigation. Once produced, MT has been shown to directly influence the growth and metabolism of intestinal microbes, affecting community diversity and abundance at various taxonomic levels. Interestingly, MT also induces intestinal microbiota remodeling, improving intestinal health by reducing oxidative stress, autophagy, and inflammation—a phenotype transferable via fecal microbiota transplantation172. The interaction between MT and microbes appears to be mediated indirectly through host immune responses and microbial modulation. Further research is needed to clarify whether microbes possess specific receptors for MT. The impact of MT, particularly intestinal MT, on health outcomes remains poorly characterized, and its interaction with beneficial and pathogenic microbes requires further elucidation. MT is widely used as treatment for different populations and diagnoses, including insomnia, sleep regulation issues in individuals with blindness or traumatic brain injury, and neurological or psychiatric disorders173–176. In sepsis, characterized by inflammation, oxidative stress, and mitochondrial dysfunction, MT has shown beneficial effects, significantly reducing inflammatory biomarkers and improving sepsis outcomes in neonates177,178, and in mice infected with S. aureus and Escherichia coli, MT administration resulted in better clearance of the bacteria from blood179. An in vitro study suggested that MT’s efficacy in sepsis may be due to its ability to reduce mitochondrial dysfunction, oxidative stress, and cytokine responses180. In humans, evidence regarding the effect of MT on activity of inflammatory bowel disease is conflicting. Some case reports show symptom improvement with MT intake181, while others report aggravation182. Patients with ulcerative colitis have lower colonic MT levels, which negatively correlated with disease severity141. A small cohort study found improved biopsy results in patients with inflammatory bowel disease who received MT alongside regular treatment183. In children with neurodevelopmental abnormalities, MT improved gastrointestinal symptoms, including gastro-esophageal reflux, ulcerative colitis, and non-specific chronic diarrhea184. Probiotics may influence MT production, as symptom improvement in patients with irritable bowel syndrome correlates with higher morning MT levels following probiotic intake185. In animal models, MT has been shown to prevent obesity186–190. A decreased abundance of Bacteroidetes and increased abundance of Bacillota has been found in obese rodents191,192 and humans193. In mice fed a high-fat diet, MT supplementation significantly increased Bacteroidetes and decreased Bacillota levels149. MT supplementation was also associated with an increased abundance of Akkermansia, a bacterial genus that has been associated with improved metabolic health, such as decreased rates of obesity, diabetes and inflammation in rodents194–196 and humans197,198. Similarly, MT supplementation was associated with lower abundances of Alistipes and Anaerotruncus, both of which have been associated with obesity199,200. Shift work is associated with systemic inflammation and a higher risk for cancers, allergies and autoimmune diseases201,202. Shift workers have a higher incidence of breast and prostate cancers, potentially linked to chronically reduced MT levels203–205. Night shift workers also show increased markers of systemic inflammation, including increased leukocyte counts206, and are at higher risk for high blood pressure207 and metabolic syndrome206–209. Sleep deprivation is linked to a higher risk for ulcerative colitis202, possibility due to MT suppression108. MT attenuates intestinal microbiota dysbiosis (such as reduced diversity, lower abundances of Akkermansia, Bacteroides, and Faecalibacterium, and a higher abundance of Aeromonas) induced by sleep deprivation in mice108,109, while improving the intestinal barrier function108,140,145. Furthermore, MT reverses sleep deprivation-induced intestinal microbiota dysbiosis by suppressing oxidative stress and inflammation109. MT might be a valuable therapeutic agent for dysbiosis-related conditions and disturbances in the gut-brain axis, affecting both gastrointestinal health and neurological functions. Current studies focus on engineering E. coli210–212 and S. cerevisiae213 to synthesize large amounts of MT. However, more research is required to identify which intestinal microbes produce MT, their interactions with other microbes, and whether co-administration of MT with synbiotics could enhance health outcomes. It remains unclear whether MT-producing microbes self-regulate their functions or if environmental MT influences the cellular regulation of various microbial species. This distinction is significant as it could impact our understanding of microbial behavior and their interactions with the host environment.